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pilottituoleihin valituille moduulille tehdyt LabVIEW-ohjelmat ja tarvittavat kytkennät. Nämä mahdollistivat 
mittausmoduuleilla monitoroinnin. Tarkoituksena oli myös suunnitella, toteuttaa ja testata pulssiaikaviiveellä 
toteutettu potilaan systolisen verenpaineen arviointi. Potilaan EKG oli tarkoitus mitata kuivaelektrodeilla, 
joiden toteutus esitellään. Tarkoituksena oli myös toteuttaa automatisoitu RR- ja QT-intervallien mittaus 
valitulle EKG-moduulille. Myös tiedon keruu pilottien kehitysvaiheista oli osatavoitteena diplomityössä. 
Diplomityö esittelee terveystuolin ensimmäisen pilotin, joka toimi koealustana valituille moduuleilla. Sen 
tarkoituksena oli kokeilla moduulien toimivuus käyttötarkoitukseen. Käyttöönottoon tehdyt tarvittavat 
LabVIEW-ohjelmat ja kytkennät tehtiin ja ne esitellään. Terveystuolin toinen pilotti toimi koekäyttötuolina ja 
muistutti enemmän lopullista terveystuolia. Se sisälsi verenpaine-, paino-, plethysmografia-, kudosimpedanssi-
, happisaturaatio- ja sykemittaukset.  Näihin toteutetut ohjelmat ja kytkennät esitellään. Kolmas pilotti ei 
valmistunut tämän diplomityön aikana. Sen kehitys oli tarkoituskin jatkua. Tuolin oli tarkoitus sisältää EKG-, 
paino-, kudosimpedanssi-, happisaturaatio-, syke- ja plethymografiamittaukset sekä systolisen verenpaineen 
arvioinnin pulssiaikaviiveen avulla. Diplomityö esittelee siihen kuivaelektrodi kytkennän, joka suunniteltiin 
EKG-mittaukseen. Tehdyt RR-ja QT-intervallien automaattiset mittausmenetelmät esitellään. Suunnitellut 
menetelmät systolisen verenpaineen arviointiin pulssiaikaviiveellä esitellään. 
Diplomityössä toteutettiin mittaukset onnistuneesti jokaiseen siinä käytettyyn mittausmoduuliin. Työssä 
suoritettiin kokeita viidelle henkilölle. Ensinnäkin terveystuolin toisen pilotin mittaukset suoritettiin. Tulokset 
esitellään ja todettiin että kaikki mittaukset on toteutettavissa.  Toiseksi RR- ja QT-intervallien automaattinen 
laskenta testattiin. LabVIEW-ohjelman laskemia tuloksia verrattiin MatLabilla manuaalisesti mitattuihin 
tuloksiin. RR-intervalleilla oli pienempi standardi deviaatio ja pienempi mediaani virhe kuin QT-intervalleilla.  
Ne saavuttivat tyydyttävän tarkkuuden. Viimeiseksi systolisen verenpaineen arviointi pulssiaikaviiveellä 
kokeiltiin kahdella eri tavalla. Tuloksissa todetaan että pulssiaikaviive ei ole sopiva absoluuttisen verenpaineen 
arviointiin, eikä sen tarkkuus riitä huomioimaan pieniä verenpaineen muutoksia, mutta se voisi olla sopiva 
menetelmä pitkä aikaiseen verenpaineen seurantaan. 
 
 
 
 
Avainsanat: terveystuoli, monitorointi, elektrokardiogrammi, pulssioksimetri, happisaturaatio , LabVIEW, 
plethysmogrammi, pulssiaikaviive, RR-intervalli, QT-intervalli 
iii 
 
 
 
Preface 
This master’s thesis was made in Aalto University School of Electrical Engineering in 
laboratory of Applied Electronics. The writer did not do all of the electronics, programs, 
done physical work or designs. Health chair pilots were results of teamwork. 
 
I want to thank my thesis supervisor professor Raimo Sepponen from the possibility to 
do the thesis. Also, I want to thank Mikko Paukkunen and Heikki Ruotoistenmäki for 
all the help. Above all I want to thank Matti Linnavuo for crucial advises and help, even 
during his holidays.   
 
“It is clear that bioengineers of the future will have a tremendous impact on the quality 
of human life.” - Joseph D. Bronzino, The Biomedical Engineering Handbook. 
 
Helsinki 26
th
 of September, 2013 
 
 
Ville Mustonen 
  
 
 
Contents   
ABSTARCT OF THE MASTER´S THESIS ..................................................................... i 
DIPLOMITYÖN TIIVISTELMÄ (FINNISH) ................................................................. ii 
Preface .............................................................................................................................. iii 
Contents ........................................................................................................................... iv 
Presented figures ............................................................................................................... v 
Presented tables .............................................................................................................. viii 
Symbols and abbreviations .............................................................................................. ix 
1 Introduction ............................................................................................................... 1 
1.1 Background ........................................................................................................ 1 
1.2 Related researches .............................................................................................. 1 
1.3 Aim of this thesis ................................................................................................ 2 
1.4 Introduction to the thesis .................................................................................... 2 
2 Physiology related to the measurements ................................................................... 4 
2.1 Physiology of heart ............................................................................................. 4 
2.1 Cardiac conduction system ................................................................................. 4 
2.2 Cardiac cycle ...................................................................................................... 5 
2.3 Pulse and heart rate ............................................................................................. 5 
2.4 Blood pressure .................................................................................................... 6 
3 Theory of the measurements ..................................................................................... 7 
3.1 Electrocardiography ........................................................................................... 7 
3.1 Pulse oximetry .................................................................................................. 10 
3.2 Blood pressure measurements .......................................................................... 15 
3.3 Bioelectrical impedance ................................................................................... 19 
4 First pilot ................................................................................................................. 25 
4.1 Aim of the first pilot ......................................................................................... 25 
4.2 Outlines of the first pilot .................................................................................. 25 
4.3 Realization of the first pilot .............................................................................. 25 
4.4 Software of the first pilot .................................................................................. 27 
4.5 Discussion on the first pilot .............................................................................. 31 
5 Second pilot ............................................................................................................. 32 
5.1 Aim of the second pilot .................................................................................... 32 
5.2 Outlines of the second pilot .............................................................................. 32 
5.3 Realization of the second pilot ......................................................................... 32 
5.4 Software of the second pilot ............................................................................. 34 
5.5 Discussion on the second pilot ......................................................................... 40 
6 Third pilot ............................................................................................................... 42 
6.1 Aim of the third pilot ........................................................................................ 42 
6.2 Outlines of the third pilot ................................................................................. 42 
6.3 Realization of the third pilot measurements ..................................................... 42 
6.4 Software of the third pilot ................................................................................ 45 
6.5 Discussion on the third pilot ............................................................................. 48 
7 Tests and results ...................................................................................................... 49 
7.1 Aim of the tests ................................................................................................. 49 
7.2 Tests and results ............................................................................................... 49 
7.3 Conclusion ........................................................................................................ 60 
8 Summary ................................................................................................................. 62 
Bibliography .................................................................................................................... 64 
List of appendices ........................................................................................................... 68 
  
 
 
v 
Presented figures 
Figure 1 presents the anatomy of the heart: its atriums, ventricles, associated major ves-
sels and cardiac conduction system. (Webster 2010, p. 148) 
 
Figure 2 presents Einthoven limb leads (R, L, F) and Einthoven triangle is marked with 
blue. (Malmivuo & Plonsey 1995, figure modified) 
 
Figure 3 describes the normal electrocardiogram where QRS-complex and P-,T-,U-
waves can be noted. (Malmivuo & Plonsey 1995, figure modified) 
 
Figure 4 clarifies formation of ECG signal in the Einthoven leads. Einthoven triangle 
marked with blue. Resultant vector of electrical activity wave front (green) is illustrated 
with thick yellow arrow. (Malmivuo & Plonsey 1995, figure modified) 
 
Figure 5 is a typical view of pulse oximetry where plethysmogram wave, SpO2 and 
pulse rate is shown. (Urpalainen 2011, p. 9) 
 
Figure 6 includes components of pulse oximeter finger probe. (Moyle 2002, p. 18) 
 
Figure 7 presents the absorption spectra of oxygenated and deoxygenated haemoglobin 
on the most used wavelengths. (Moyle 2002, p.16, figure modified) 
 
Figure 8 present a basic demonstration of oximeter. (Modified from Upralainen 2011 p. 
10; Baura 2002 p.73) 
 
Figure 9 presents a typical photoplethysmographic signal. (a) A raw signal measured 
from a photo detector. (b) Final signal, constant k-reflect light intensity.  (Lee et al. 
2011) 
 
Figure 10 shows the definition of pulse transit time in various studies. (McCarthy et al. 
2011) 
 
Figure 11 describe determination of the virtual base point or P-base point. (Hey et al. 
2009) 
 
Figure 12 shows the cylinder model from the relationship between impedance and ge-
ometry. (Kyle et al. 2004) 
 
Figure 13 describe Fricke’s electrical model and circuit presentation on the right after 
simplification. Membrane resistance Rm is very small and thus disregarded. (Ruiz 2011 
p.6; figure modified) 
 
Figure 14 presents Cole-Cole plot where phase angel’s (φ) relationship with resistance 
(R), reactance (XC) and impedance (Z) are presented.  (Kyle et al. 2004) 
 
Figure 15 a two-electrode bioelectric impedance instrumentation setup. In figure Zep is 
sensing electrode polarization impedance, VTUS is measured voltage in tissue under 
study and ZTUS its impedance and Vm measured voltage. 
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Figure 16 presents a four-electrode bioelectric impedance instrumentation setup. In fig-
ure Zep is sensing electrode polarization impedance, VTUS is measured voltage in tissue 
under study and ZTUS its impedance and Vm measured voltage. 
 
Figure 17 presents EMB1 LabVIEW VI hierarchy. 
 
Figure 18 presents VI hierarchy of ChipOx LabVIEW user interface. 
 
Figure 19 presents second stage pilot design. Blood pressure cuff and photoplethysmog-
raphy finger clip can be seen hanging on the left armrest. Stainless steel sensors and 
user monitor are clearly detectable. 
 
Figure 20 presents VI hierarchy of EG00352. Figure clarifies functioning of EG00352 
and Find POX VIs 
 
Figure 21 presents NIBP VI block diagram. 
 
Figure 22 represents VI hierarchy of electrical bioimpedance measurement 
 
Figure 23 presents VI hierarchy of weight measurement program. 
 
Figure 24 presents block diagram, which clarifies initializing of measurements. 
 
Figure 25 presents main page shown for user. Measurement tabs can be seen under text 
where information for user is shown. 
 
Figure 26 (a.) presents effect of a voltage transient on an ECG. (Webster 2010, p. 256, 
picture modified) and (b.) presents EMG interference on the ECG. (Webster 2010, p. 
256, picture modified) 
 
Figure 27 presents amplifier circuit made to OPA277. 
 
Figure 28 presents schema from designed active electrode AD8627 amplifier circuit 
with low pass filter. 
 
Figure 29 presents designed measurement circuit with AD8627 active electrodes and 
EMB1 ECG module. 
 
Figure 30 clarify how QT interval was detected from two consecutive RR intervals. 
 
Figure 31 presents ECG signal drawn with Matlab. RR interval was calculated from 
peak of R wave to the peak of next wave and QT interval was calculated from the be-
ginning of Q valley to the end of T wave. 
 
Figure 32 present two PQRST complexes from each test person. 
 
Figure 33 presents systolic blood pressure estimations and measured systolic blood 
pressures from test person A. 
 
Figure 34 presents systolic blood pressure estimations and measured systolic blood 
pressures from test person B. 
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Figure 35 presents systolic blood pressure estimations and measured systolic blood 
pressures from test person C. 
 
Figure 36 presents systolic blood pressure estimations and measured systolic blood 
pressures from test person D. 
 
Figure 37 presents systolic blood pressure estimations and measured blood pressures 
measured from person E. 
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Presented tables 
Table 1 presents EMB1 packet structure and descriptions of individual fields 
(Corscience EMB1 2010, p. 16) 
 
Table 2 describes data packet octet stuffing (Corscience EMB1 2010, p.17) 
 
Table 3 presents data packet structure of ChipOx module and clarifies meaning of it 
parts. (Corscience ChipOx 2010, p.23) 
 
Table 4 presents communication layer is completely contained in Data-block in transfer 
layer. (Corscience ChipOx 2010, p.24) 
 
Table 5 presents definitions of the marker bytes in EG00352 (Medlab EG00352 2012, p. 
10) 
 
Table 6 presents NIBP’s eight ASCII frames (Medlab NIBSCAN 2012, p.6) 
 
Table 7 presents requirements and possibilities of each profile 
 
Table 8 presents firstly measured parameters from test persons 
 
Table 9 presents measured parameters from second pilot design 
 
Table 10 presents median values and standard deviations from measured and calculated 
RR and QT intervals. 
 
Table 11 present estimated and measured blood pressures from person A 
 
Table 12 present estimated and measured blood pressures from person B 
 
 
Table 13 present estimated and measured blood pressures from person C 
 
Table 14 present estimated and measured blood pressures from person D 
 
Table 15 present estimated and measured blood pressures from person E  
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Symbols and abbreviations 
 
Symbols 
AT  total absorbance at wavelength λ 
I  transmitted light 
I0 incident intensity 
Pb  base blood pressure 
Pe  estimated blood pressure 
Tb PAT value corresponding base blood pressure 
V  volume 
Vep electrode polarization voltage 
VTUS  measured voltage in tissue under study 
ZTUS  impedance in tissue under study  
   absorptivity of the absorbent at wavelength λ 
c concentration of the absorbent 
d  optical path length 
l  optical path-length of the sample 
γ  an elastic modulus coefficient of the vessels  
   resistivity of conductive material. 
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Abbreviations 
AC  Alternating current 
Ag/Ag-Cl  Silver/silver-chloride 
ASCII  American standard code for information interchange 
AV  Atria ventricular 
BELA  Body electrical loss analysis 
BIA  Bioelectrical impedance analysis 
BP  Blood pressure 
BPV  Blood pressure variability 
BW  Body water 
CRC  Cyclic redundancy check 
DBP  Diastolic blood pressure 
DC  Direct current 
EBI   Electrical bioimpedance 
ECG  Electrocardiography 
ECW  Extra cellular water 
FFM  Fat free mass 
GUI  Graphical user interface 
Hb  Reduced haemoglobin 
HbO2  Oxygenated haemoglobin 
HEMA  Institute of Healthcare Engineering, Management and Archi-
tecture 
HR  Heart rate 
HRV  Heart rate variability 
LabVIEW Laboratory Virtual Instrumentation Engineering Workbench 
LSB Least significant bit 
MF-BIA  Multi frequency bioimpedance analysis 
MV  Minute volume 
NIBP  Non-invasive blood pressure 
OEM  Original equipment manufacturer 
PAT  Pulse arrival time 
PEP  Pulse-ejection time 
POX  Partial oxidation 
PPG   Photoplethysmography 
PPP  Point-to-Point Protocol 
PTT  Pulse transit time 
PWV  Pulse wave velocity 
SA  Sinoatrial 
SBP  Systolic blood pressure 
SF-BIA  Single frequency bioimpedance analysis 
SpO2  Peripheral blood oxygen saturation 
TBW  Total body water 
VI  Virtual instrument 
VISA  The Virtual Instrument Software Architecture 
bpm  beats per minute 
dia  diastolic 
mmHg millimeters of mercury 
subVI  sub virtual instrument 
sys  Systolic
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1 Introduction 
1.1 Background  
In developing countries and in majority of developed countries cardiovascular diseases 
are the major death cause in adults and in the elderly people.  The diseases result in sub-
stantial disability and loss of productivity. They escalate the costs of health care, espe-
cially in presence of elderly people. (Sans et la. 1997)  Cardiovascular diseases are the 
main cause of death within the range of 44-64 years, and the second most frequent 
cause of death of people between 24 and 44 years. An early recognition of symptoms, 
and warning of the patient or doctor, would enable preventive actions to avoid the attack 
and thus the risk of irreparable damage to organs or even death. Rapid advancement of 
medical technology has contributed to significant improvement in patient care. Partly 
because of technologies advanced, within the last 20 years the life expectancy has shift-
ed from about 72 years to 80 years. At the same time, the costs of health care have in-
creased due to treatments. The challenge for today’s engineers is to develop new or im-
proved methods of preventive care and to decrease the costs of instrumentation as well 
as its use. (Gruetzmann 2007) 
  
Monitoring is repeated testing aimed to guide and manages chronic or recurrent condi-
tion. Monitoring is a central activity in the management of patients and a major part of 
the ritual of routine visits for most chronic diseases. Measuring patient’s current state 
and responses to treatment is essential to managing many diseases. At the moment, 
many acute diseases diagnosis begins with clinical diagnosis testing. This focus should 
soon shift to monitoring to effectiveness the treatment. (Glasziou et al. 2008) Aim of 
patient monitoring is to help to evaluate important physiological variables during want-
ed moments. These values or changing trends are important to know for their clinical or 
research evaluation.  At the end, patient monitoring aims to prevent patient losses by: 
 
 Organizing information  
 Displaying the information in form that eases the care of patient 
 Comparing multiple factors that it would be possible to show clear presentation 
of clinical problems  
 Processing information that alarms can be set 
 Producing information leaning on automatically collected information 
 Making better care with less healthcare personnel possible (Reijula 2007, p. 11-
12) 
 
This master’s thesis and research related are focused to develop an innovative health 
chair for monitoring patient’s cardiovascular state. 
1.2 Related researches 
This thesis is part of larger investigation conducted by Aalto Health Factory. It is a part 
of Aalto University concentrated to advance health and welfare technology. The aim of 
this project is to design and implement a chair for monitoring patient’s cardiovascular 
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state of health. The whole project aims to result in a product to do fast and easy cardio-
vascular measurements, all collected in health chair. Aim of the project is to provide an 
inexperienced easiness for wanted patient measurements and to integrate the existing 
measurements to one health chair concept.  
 
Participants in the project of the health chair were the Institute of Healthcare Engineer-
ing, Management and Architecture (HEMA). It is a research group concentrated on the 
production and development of health services. HEMA is part of Aalto University 
(HEMA 2013). To technical development of the chair were mainly participated staffs of 
Aalto University’s laboratory of Applied Electronics. On the first state, the technical 
main focus of this research project is to actualize a working pilot designs from patient 
monitoring health chair, which would be further developed afterwards. This master’s 
thesis has been written during that time.                           
1.3 Aim of this thesis 
Aim of this master’s thesis is to participate in to technical development of the health 
chair by realizing wanted measurements to health chair pilot designs from selected 
OEM (Original Equipment Manufacturer) modules. This includes doing all the neces-
sary coupling and programming to implement the measurements. The measurements 
realized to second pilot design were tested. Tests were conducted to confirm the meas-
urements could be done. In addition, aim was to design automated calculations of RR 
and QT intervals from ECG module and test their compatibility to use. Aim was also to 
design, execute and test estimating of patient blood pressure from pulse transit time 
(PTT). Two different estimating methods was implemented and tested. The thesis intro-
duces a design of dry-electrode contact electrocardiography (ECG) measurement from 
chosen OEM module. It also collects information related from realized pilot designs 
measurements. 
1.4 Introduction to the thesis 
The aim of the thesis was not to make a product, but to realize pilot design for devel-
opment of a product. The electronics were mostly made using OEM modules to speed 
up development process; exceptions are explained in subsequent chapters. The pro-
grams were mostly implemented with LabVIEW (Laboratory Virtual Instrument Engi-
neering Workbench) program. The information in this master’s thesis is limited to only 
measurements realized in the pilot designs. The aim of the thesis is not to decide the 
factors measured to monitor patient’s health state or methods used to estimate patient’s 
state of health. The thesis is a part of the larger project, which aims to commercialize 
the health chair product and have been done by instructions and directions given. 
 
This master’s thesis explains and clarifies work done related to bioelectrical instrumen-
tation and programs designed during the research. Firstly the thesis introduces theoreti-
cal physiological background of realized measurements. It introduces the fundamentals 
of physiology to help to understand the fundamentals of measurements. Only necessary 
information to reader is introduced. It explains the fundamentals of human cardio-
vascular system to help to understand the fundamentals of electrocardiography. The 
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thesis explains related issues from physiology of blood pressure. Secondly, the master’s 
thesis introduces shortly theory how measurement devices functions. Also, the basics of 
health information, which measurements provide, are introduced.  After, it introduces 
pilot designs and realized programs, electronics and ensembles done during the thesis 
process. The part tells the measurement devices chosen and pilot design made. It ex-
plains the design and implementation process of the devices. In this part, the design and 
programming of communication and the graphical user interface (GUI) is also ex-
plained. The health chair’s pilot designs and their parts made will be introduced in 
chronological order.  Lastly, the thesis introduces test and results done and discusses 
about result and possible improvements to the health chair.   
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2 Physiology related to the measurements 
2.1 Physiology of heart 
The heart is the pump that circulates blood in cardiovascular system. The heart rests 
near midline of thorax. About two thirds of its mass is on left of the bodyline. Its aver-
age mass is 250 grams in adult females and 300 g in adult males. It is surrounded by 
pericardium, which surrounds and protects the heart. It confines the heart to its position 
and gives it sufficient freedom to move in rapid contradictions. The walls of the heart 
consist from three layers: the epicardium, the myocardium and the endocardium. The 
epicardium is the external layer and it gives the slippery texture to the outermost surface 
of the heart. The myocardium is the cardiac muscle tissue and it is responsible of pump-
ing action. The endocardium provides a smooth lining for the chamber and covers the 
heart valves. The heart has four chambers. It has two superior chambers, which are 
called atria’s. The two inferior chambers are ventricles. Figure 1 presents the anatomy 
of the heart: its atriums, ventricles, associated major vessels and cardiac conduction 
system. (Tortora & Derrickson 2007, p. 696-699) 
 
Figure 1 presents the anatomy of the heart: its atriums, ventricles, associated major vessels and cardiac 
conduction system. (Webster 2010, p. 148) 
2.1 Cardiac conduction system 
Contraction of heart muscle cells requires depolarization, plateau and repolarization 
phase of their cell membranes caused by movement of ions. (Malmivuo & Plonsey 
1995, Tortora & Derrickson 2007, p. 712) Heart’s specialized muscle fibres are called 
autorhytmic fibres because they are self-excitable. About 1% of heart’s cardiac muscle 
fibres are autorhytmic fibres. They work as a source of heart’s electrical activity. Auto-
rhytmic fibres act as a specialized network repeatedly generating action potential and 
making heart to contract. The most importantly they work as pacemaker cell making 
heart to contract. They form the conduction system which is able the cardiac excitation 
to conduct through heart. This ensures that the chambers of heart contract in needed 
manner. (Tortora & Derrickson 2007, p. 710) 
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The cardiac action potential propagates through the conduction system in the following 
way. The wave is generated in sinoatrial (SA) node. It is located in right atrial wall. SA 
node cells depolarize repeatedly and spontaneously. SA node cells do not have stable 
resting potential.  This depolarization is called pacemaker potential. When it reaches its 
threshold it triggers the action potential. Action potentials propagate from SA node to 
via gab junction to atrial muscle fibres, what is followed by atrial contraction. After the 
atrial depolarization it reaches atrioventricular (AV) node, which is located in septum 
between the atria’s. From AV node wave propagate AV bundle. It is the only site where 
wave can conduct from atria to the ventricles. Wave’s propagation is slowed down in 
AV node, because fibres here have fewer gab junctions and smaller diameter. This 
pause enables ventricular filling and is desired. After AV bundle propagation reaches 
the ventricles and then proceeds along right and left bundle branches to Purkinje fibres 
to inner walls of ventricles. (Malmivuo & Plonsey 1995; Tortora & Derrickson 2007, p. 
710-714) The cells constituting from ventricular myocardium are coupled together by 
gap junctions. Healthy ventricular myocardium has very low resistance. In heart propa-
gating wave can propagate to areas, which are still at rest potential.  Studies show that 
activation wave front proceeds uniformly from endocardium to epicardium and from 
upper section to lower section. (Malmivuo & Plonsey 1995) 
2.2 Cardiac cycle 
Cardiac cycle includes all events in one heartbeat. It consists from atrial systole and 
diastole and also ventricular systole and diastole. In cardiac cycle the atria’s and ventri-
cles contract and relax forcing blood from higher-pressure areas to lower pressure areas.  
Cardiac cycle starts from atrial systole where atria’s are contracting and ventricles are 
relaxed. Depolarization of the SA node causes the atrial depolarization, when atrial sys-
tole starts. Atrial contraction force blood from atria’s to ventricles. It is followed by 
atrial diastole and ventricular systole. In ventricular systole the ventricles are contract-
ing. It is caused by ventricular depolarization. Ventricular systole forces blood from 
ventricles to aorta and pulmonary trunk. Ventricular systole is followed by ventricular 
diastole caused by repolarization. Last period during cardiac cycle is relaxation period 
then both atria’s and ventricles are both relaxed. When ventricular pressure drops lower 
than atrial pressure ventricular filling starts. (Tortora & Derrickson 2007, p. 716) 
2.3 Pulse and heart rate 
Pulse is pressure wave resulting from heart’s pumping. It is born when blood is rushing 
out from left ventricles during systole and expanding walls of aorta. During diastole 
pulse is born when blood pressure decreases and walls of arteries squeeze the blood 
forward. Pulse is raised from the bottom of the aorta. Pulse advances wave like in the 
arteries. It advances faster than blood circulating in arteries. Pulse can be detected from 
multiple of the largest arteries. (Haarnoja 2012, p. 8-9) Heart rate is amount of heart-
beats per amount of time. It is normally measured in beats per minute (bpm). Without 
hormonal or neural effect, human heart would beat 100 times per minutes. This is the 
rhythm of SA node impulses.  With hormonal and neural effect heart beat rate can be 
more or less. Pulse rate is normally same as heart rate. (Tortora & Derrickson 2007, p. 
753) The beat-to-beat heart rate variability (HRV) is well known to carry a great deal of 
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information about the dynamic features of cardiovascular control mechanisms. (Ma & 
Zhang 2005) 
2.4 Blood pressure 
Blood pressure maintains the circulation in our bodies so that oxygen and nutrition 
transportation to cells are working. It transports necessary nutrition and oxygen to cells 
and removes their waste products. When blood pressure is too high it can damage tis-
sues and cells in our body. The circulatory system consists from two circulatory sys-
tems: pulmonary circulation and systemic circulation. Pulmonary circulation circulates 
the blood through lungs and pulmonary system.  Systemic circulation circulates through 
rest of our body. Blood is moved through these systems by two pumps, the right and left 
ventricles of the heart. The left side of the heart carries heavier workload, because push-
ing blood through muscles is heavier. Blood is under pressure at all points through out 
both systems in arteries, capillaries and veins otherwise it would not circulate. (Fahey et 
al. 2004, p.7-8; Larkin 2005, p.10)  
 
Blood pressure is determined by the amount of blood ejected into circulation (cardiac 
output) and the forces of the circulatory system that impede blood flow (total peripheral 
resistance). Cardiac output is determined by heart rate and stroke volume, increase in 
one increases blood pressure at the end. Total peripheral resistance is compromised of 
the degree of vasodilation and vasoconstriction. All physiologic and physiological states 
that affect blood pressure will do so by altering cardiac output, total peripheral re-
sistance or combination of two. (Larkin 2005, p.9) Several systems of the body directly 
influence blood flow through the body and the magnitude of the blood pressure, includ-
ing: 
 
 The metabolic demands of the local tissue and associated blood vessels 
 The autonomic nervous system 
 The neuroendocrine system the excretion of fluid by the kidney 
 Extensive feedback system that involves central nervous activity (Larkin 2005, 
p. 9-10)   
 
Systolic blood pressure (SBP) is the force of blood pressure on arterial walls just after 
ventricular contraction. Diastolic blood pressure (DBP) represents the force remaining 
in the arteries during ventricular relaxation. (Tortora & Derrickson 2007, p. 754) Blood 
pressure is typically described first systolic and then diastolic and it is described with 
millimeters of mercury (mmHg) because of mercury used in historical measuring devic-
es. An average healthy blood pressure of a person is 125/70 mmHg. (Fahey et al. 2004 
p.11; Larkin 2005 p. 32). According to Ma & Chang (2005), especially in recent years, 
blood pressure variability (BPV) receives increasing attention because it provides inde-
pendent information about autonomic cardiovascular regulation and prognostic indica-
tions for cardiovascular mortality. Many studies have been carried out in order to corre-
late BPV with various pathologies in autonomic nervous system.  
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3 Theory of the measurements 
3.1 Electrocardiography 
Electrocardiography (ECG) is registering heart’s electrical action potentials. These ac-
tion potentials are rather strong. They are conducted through whole body because of 
body’s own fluids thus they can be detected almost anywhere from the surface of hu-
man body. To make ECG measurement results comparable with each other, there have 
been developed standard measurement methods. With continuous ECG recording the 
exceptional electrical or muscular behaviour can be detected. (Haarnoja 2012, p.11)   
 
The 12-lead ECG system is most commonly used clinical ECG system. There six of 
electrodes are attached to the limbs, so called precordial leads, and three to the limbs, so 
called limb leads. Last three of leads are called Einthoven leads. Einthoven leads, pre-
sented in figure 2 R,L and F, describes potential differences of certain points.  Over 
90% of heart’s electrical activity could be sufficiently explained with these three leads. 
Two of the limb leads and one precordial limb lead would be needed. (Malmivuo & 
Plonsey 1995) 
 
Figure 2 presents Einthoven limb leads (R, L, F) and Einthoven triangle is marked with blue. (Malmivuo 
& Plonsey 1995, figure modified) 
 
Einthoven triangle, marked with blue in figure 2, is an approximate description of the 
lead vectors associated with the leads. Einthoven limb lead placements are used in ECG 
signal recordings to detect ECG signal. The voltages measured by the three limb leads 
are proportional to the projections of the electric heart vector on the sides of the lead 
vector triangle, Einthoven limb leads are defined in the following way. 
  
 Lead I: VI  = ΦL – ΦR 
Lead II: VII  = ΦF - ΦR 
Lead III: VIII = ΦF - ΦL 
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, where VI = the voltage of Lead I 
VII = the voltage of Lead II 
VIII = the voltage of Lead III 
ΦL = potential at the left arm 
ΦR = potential at the right arm 
ΦF = potential at the left foot 
 
In figure 3 we can see PQRST-complex of the normal healthy heart. From the complex 
we can differentiate that the P wave, which shows the amplitude and time of atrial depo-
larization. Q valley can be detected after P wave. QRS-wave has the biggest amplitude 
and it is result from ventricular depolarization. T wave is the result of ventricular re-
polarization. Figure 3 also presents QT interval, which is calculated from beginning of 
Q wave to the end of T wave. RR interval is interval between R peaks of two separate 
PQRST complexes. According to Baura (2002, p. 166) ECG signals are typically in the 
range of ± 2mV and require bandwidth of 0,005 to 150 Hz to be recorded. 
 
 
Figure 3 describes the normal electrocardiogram where QRS-complex and P-,T-,U-waves can be noted. 
(Malmivuo & Plonsey 1995, figure modified) 
 
The generation of actual ECG wave can be described by supposing that one side of the 
cells are completely at rest phase, their potential is zero. Through cardiac conduction 
system explained, a propagating wave once initiated continues to propagate to the parts 
still at rest, because of very low resistance of the heart.  In figure 4 formation of ECG 
signal in the Einthoven leads is presented. (Malmivuo & Plonsey 1995) 
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Figure 4 clarifies formation of ECG signal in the Einthoven leads. Einthoven triangle marked with blue. 
Resultant vector of electrical activity wave front (green) is illustrated with thick yellow arrow. (Malmivuo 
& Plonsey 1995, figure modified) 
 
In figure 4, formation of ECG signal in the Einthoven leads is presented. Next presenta-
tion assumes that heart has electrophysiological behaviour of uniform fibres and the 
sequence of activation wave front has been plotted from which spatial gradient is taken. 
The formation of ECG signal in the Einthoven leads can be described by following way: 
1. Electrical activation begins at sinus node and the wave front spreads along atrial 
walls.  The resultant vector compared on each measuring leads is positive. 
2. Next propagation reaches the AV node where the propagation wave is slowed 
down, when P wave is formed. Once the wave has reached the ventricles the 
propagation proceeds along the Purkinje fibres to inner wall. This ventricular 
depolarization starts from the left side of the walls separating ventricles, called 
ventricular septum, and therefore resultant dipole point to right. This causes a 
negative signal in leads I and II which forms Q valley. 
3. Then propagating wave occurs in both sides of the septum and their electric 
forces cancel. At the same time activation in apex is occurring when the result-
ant vector points to apex. 
4. Then the propagating wave reaches the wall of right ventricle and last the wall 
of left ventricles, because on the ventricular wall is thicker. This is how the acti-
vation on left ventricle can continue even after right ventricle’s depolarization. 
n. Because there are no compensating forces on right, the resultant vector point-
ing left reaches it maximum, R peak is formed.  
5. After the depolarization wave continues to propagate. Because its area is contin-
uously decreasing, the magnitude is continuously decreasing.  
6. Until the whole ventricular muscle is depolarized.  
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7. The last to depolarize are basal regions of the ventricles, T wave is formed. 
(Malmivuo & Plonsey 1995) 
 
In clinical practice it is possible to make accurate ECG diagnoses in some diseases and 
to estimate other diseases with acceptable probability from it. According to Malmivuo 
& Plonsey (1995), cardiac diagnosis often needs to be verified or completely made with 
other diagnostic methods. There are many main application areas of ECG diagnosis, but 
relevant, when considering health chair, are arrhythmias and disorders in the activation 
sequence. Basics of cardiac rhythm diagnosis are differentiation in PQRST-wave. Be-
cause anatomical differentiations depolarization and repolarization produce clearly dif-
ferentiable reflections identification of normal QRS-complex from the P and T wave 
does not create difficulties. One of possible diagnoses made with health chair could be 
atrial flutter when the heart is sufficiently elevated so that isoelectric interval between 
the end of T and beginning of P disappears. In atrial flutter impulses, travel in circular 
course in atria. When atrial activation is fully irregular and produces irregular fluctua-
tions in baseline it is called atrial fibrillation. In ventricular arrhythmias ventricular de-
polarization is distorted and is clearly detectable because of its high amplitude. 
(Malmivuo & Plonsey 1995) Disorders in activation sequence can be detected by ana-
lysing QT and RR intervals. QT interval means the time interval between the Q wave 
and the end of T wave. RR interval means the time interval between R peaks of the two 
consecutive waves. These intervals give essential information about risk of sudden 
death or dangerous arrhythmias. (NIH 2013) 
3.1 Pulse oximetry  
Pulse oximetery is a monitoring technique for monitoring patient’s partial blood oxygen 
saturation (SpO2), plehtymography signal and pulse rate. Plethysmography signal tells 
the changes of volume of blood in the part measured, for instance earflap of fingertip.   
In figure 5 is a typical photoplethysmograpic signal and SpO2 value measured with 
pulse oximeter. (Moyle 2012, p. 5, 17) 
 
Figure 5 is a typical view of pulse oximetry where plethysmogram wave, SpO2 and pulse rate is shown. 
(Urpalainen 2011, p. 9) 
 
The early generations of pulse oximeters all used same wavelengths, 660 nm (red) and 
940 nm (infrared) generated in a probe by combining light-emitting diode with a photo 
detector, thus providing a compact probe for attachment to the fingertip of ear. Modern 
pulse oximeters, for instance transmission, reflection and intrauterine, make use of other 
wavelengths. Nowadays, much greater range of wavelengths is available. (Moyle 2012, 
p. 5, 17) 
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Figure 6 includes components of pulse oximeter finger probe. (Moyle 2002, p. 18) 
 
Two-wavelength pulse oximetry is based on two principles: distinction of aerterial 
blood pulsation from other tissue and different absorption spectra of oxyhemoglobin 
(HbO2) and reduced hemoglobin (Hb). Pulse oximetry can differentiate between pulsa-
tile arterial blood and venous capillary blood, which is smooth and flowing. It is essen-
tial tool in current practice of medicine.  Current two wavelengths pulse oximeters func-
tion by comparing the absorption of energy at two-wavelengths, usually 660 nm and 
940 nm.  A value of partial blood oxygen saturation (SpO2) is determined from the ratio 
of the absorption of the energy at these wavelengths. Oximetry by any spectrophotomet-
ric method relies on the changes of absorption of electromagnetic energy with change in 
the percentage of oxygen bound to the haemoglobin molecule. Oxyhaemoglobin and 
reduced haemoglobin have their own characteristic colours described with their excita-
tion coefficient. Wavelengths most commonly used in pulse oximeters 660 nm (red) and 
940 nm (infrared) are marked to figure 7. These wavelengths have been chosen because 
of large difference between absorptions of haemoglobin (HbO2) and reduced haemoglo-
bin (Hb). (Moyle 2002, p. 15-19) 
 
 
Figure 7 presents the absorption spectra of oxygenated and deoxygenated haemoglobin on the most used 
wavelengths. (Moyle 2002, p.16, figure modified) 
 
The measuring principle of pulse oximetry is based on Beer-Lambert law. It describes 
relation of the absorption of light to the properties of material through it is travelling.   
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Figure 8 present a basic demonstration of oximeter. (Modified from Upralainen 2011 p. 10; Baura 2002 
p.73) 
 
Mathematically law can be expressed as in equation 1: 
 
     
        (1) 
 
, where  I is transmitted light 
I0 is the incident intensity 
   is the absorptivity of the absorbent at wavelength λ 
 c is the concentration of the absorbent 
 l is the optical path-length of the sample 
 
Beer-Lambert law holds only for monochromatic radiation through a homogenous and 
isotropic medium, it is valid when there is one unknown substance solution, which is 
clear and non-turbid, and constant path-length. There should not be chemical reaction 
between the absorbent and solvent and no possibility of photochemical reaction.  Alt-
hough principle of pulse oximeter relies on Lamber-Beer law, conditions make it clear 
that calibration of pulse oximeter is empirical. This is because of variable path length, 
different substances in the tissue apart from haemoglobin and the diffusion, refraction 
and reflection of the tissues. The unscattered absorbance of this process is the natural 
logarithm of the ratio of transmitted light to incident intensity  
 
      
 
  
       (2) 
 
, where  A is absorbance at wavelength λ 
 
When more than one substance absorbs light, each absorber contributes its part in total 
absorbance, presented in equation 3: 
 
    ∑        
 
     (3) 
 
, where AT is total absorbance at wavelength λ 
 n presents number of absorbers  
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If two wavelengths of light are transmitted through a sample containing only HbO2 and 
Hb, the functional arterial oxygen saturation can be determined as (Baura 2008 p. 5; 
Baura 2002 p.69): 
 
     
      
           
  (4) 
 
Because the extinction coefficient of haemoglobin and deoxygenated haemoglobin dif-
fer at each wavelength their respective concentrations can be determined from equation 
3 by solving for two unknown concentration using two wavelengths equations. These 
concentrations are substituted in equation 4 to determine oxygen saturation using two 
wavelengths the total absorbance can be written by using equation 3. 
 
                                           (5) 
 
                                               (6) 
 
, where subscript 0 refers arterial oxyhaemoglobin 
 subscript d to arterial  deoxyhaemglobin 
 subscript x refers to variable absorbance not from arterial absorbance 
 subscript y refers to nonspecific sources of optical attenuation 
 
To isolate the contributions of arterial blood, only the pulsating absorbances are ana-
lysed. By taking the time derivative from the absorbances. The last two terms in equa-
tions 5 and 6 go to zero. 
 
   
     
  
      
  
  
       
  
  
         
  
  
        
  
  
          
  
  
  (7) 
 
In addition, an assumption that blood bath length changes dl0/dt and dld/dt are equiva-
lent.  The ratio R of two absorbance derivatives remains constant: 
 
   
                
                  
  (8) 
 
Recalling the equation 4 that functional arterial oxygen saturation is calculated from c0 
= [HbO2] and cd = [Hb]. By solving the relationship of c0 and cd from equation 8, we 
get relationship of [HbO2] and [Hb]. Then by placing these to equation 4, we can calcu-
late the SpO2 value what leads to: (Baura 2002 p.69-74; Baura 2008 p. 54-55; 
Urpalainen 2011, p. 10-13) 
 
      
                  
(            )                  
   
  (9) 
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Photoplethysmogram is optically obtained plethysmogram, which is a volumetric meas-
urement of an organ. Photoplethysmographic (PPG) signal is a transmission signal of 
altering arterial blood component. It is normalized with constant component reflecting 
the absorption of static arterial blood component, venous blood and other tissues (Moyle 
2002, p. 5- 11). The most important function of PPG is to ensure the functionality of the 
pulse oximeter. If PPG signal indicates strong dissimilarity during dicrotic notch the 
SpO2 value could be unreliable. In addition, to recognizing unreliable SpO2 measure-
ment, it can also be used in diagnosing cardiac functions, vascular compliance and 
perhipheral blood flow. (Moyle 2002, p.52- 53) Researches have suggested it could be 
used to determine systolic blood pressure with pulse transit time method. (Hey et al. 
200; Espina 2006)  
 
Photoplethysmography is composed from pulsatile component (AC) and non-pulsatile 
component (DC). Ac is synchronized with the heart and to arterial pulsation, while DC 
is related to light absorption in the tissue, vein and diastolic arterial blood volume. Ac-
cording to Lambert-Beer law presented in equation 1, the photo detector detects photons 
not absorbed in blood so AC is generated by the optical path length, that changes due to 
increase of blood volume. The waveform of general PPG can be gained by inversing or 
subtracting the amount of light not absorbed at a constant. (Lee et al. 2011) Figure 9 
present a typical photoplethymographic signal. 
 
Figure 9 presents a typical photoplethysmographic signal. (a) A raw signal measured from a photo detec-
tor. (b) Final signal, constant k-reflect light intensity.  (Lee et al. 2011) 
 
The onset and peak of PPG and constant (k) can be represented with equations 10 and 
11. 
      
                               (10) 
 
, where  IH is the large value of the reflected amount of light and the onset point of 
PPG 
bdc = εdc (λ)cdc(λ) is a function of absorption  and attenuation constant 
εdc (λ) is an extinction coefficient  
 cdc(λ)  is a concentration of absorbing substance 
ddc  is optical path length 
Hb stands for haemoglobin 
 HbO2 stands for oxyhaemoglobin 
dmin  is basal diameter of arterial vessel before pulsation 
 Ionset   is a DC component and a non-pulsatile component of PPG signal 
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                               (11) 
 
, where IL is the small value of the reflected amount of light and peak of PPG point 
 Ipeak is the peak value of pulsatile PPG component 
 dmax is the maximum variation of arterial diameter during pulsation 
 
PPGs AC component can be presented by subtracting (IH) from peak (IL), in equation 
12. 
           (12) 
3.2 Blood pressure measurements 
There are variety of blood pressure measuring methods such as intra-arterial method, 
auscultatory method and oscillometric method. The first method established was direct 
intra-arterial recording method. In intra-arterial method, the catheters are positioned 
directly into circulatory system. It permits continuous measurement of blood pressure 
on a beat-to-beat basis. Thus momentary fluctuations of blood can be detected. These 
measures are still considered to be golden standards of blood pressure measurement, but 
its impracticality for clinic use is widely recognized.  A value of blood pressure is usu-
ally presented in millimetre of mercury (mmHg), for historical reasons. The primary 
method to determine blood pressure these days is auscultatory method, invented by Ri-
va-Rocci in 1896. It is non-invasive and determines the blood pressure with the help of 
cuff wrapped around arm or length. The cuff is filled until the blood flow is entirely 
blocked. When air pressure is slowly released from the cuff audible sound can be de-
tected with stethoscope, by now variety of device has invented to detect sounds auto-
matically.  Systolic blood pressure (SBP) is detected first when blood begins to resume 
and sounds can be heard.  When air pressure is lowered more, then disappearances of 
these sounds coincide with diastolic blood pressure (DBP).  In ausclutatory method the 
examiner must attend to several factors: an occluding cuff of appropriate size, standard 
arm placement, positioning of cuff at heart level having the patient adapt to stands body 
posture.  A second type of non-invasive blood pressure measurement is oscillometric 
method. It operates by sensing the magnitude of oscillations caused by the blood as it 
begins to flow again into the limb. This marked increase in amplitude of oscillation is 
SBP value. DBP value is marked when oscillations levels off. Although the oscillation 
with the greatest amplitude has been proven to reliably correspond with mean arterial 
pressure determination, SBP and DBP values are often less accurate than in auscultatory 
measures. It tends to overestimate SBP and underestimate DBP. Both auscultatory and 
oscillometric methods of blood pressure are intermittent methods. A single determina-
tion of blood pressure can take entire minute to obtain. Additionally, a brief rest period 
is recommended between the measures that allow circulation under cuff to return nor-
mal. (Larkin 2005, p. 31-35) 
 
In addition, two non-invasive blood pressure methods have been developed: the vascu-
lar unloading method and pulse transit time method. Vascular unloading method obtains 
estimates of blood pressure from small-pressurized cuff positioned over a finger in con-
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junction with photoplethysmograph. Blood flow oscillations are sensed by the encir-
cling finger cuff and translated into beat-to-beat estimates of blood pressure. The cuff 
stays pressurized during the measurement and can become uncomfortable for during 
extended measurement periods.  The method is under criticisms. Larkin (200,5 p. 35) 
tells that various studies report that it underestimates blood pressure or it over estimates 
it. Despite of its inaccuracy in the continuous finger arterial recordings, Parati (et al. 
1989) suggested that in could provide a reliable index of change in blood pressure in 
response to acute environmental stimuli. (Larkin 2005, p. 35) 
 
Another non-invasive blood pressure method is pulse transit time (PTT) method. It re-
flects the time the pulse wave takes to travel from heart to the site in peripheral circula-
tion, typically finger of earlobe. It measures the time between initiation of cardiac con-
traction from the electrocardiogram (ECG) to arrival of pulse wave at peripheral site 
measured with photoplethysmography, usually finger or earlobe. When arterial pressure 
increases the pulse wave travels more quickly and lowers pulse transit time and con-
versely when blood pressure decreases PTT lengthens (Zakaria et al. 2010; Larkin 2005 
p. 35). Although studies are comparing PTT with blood pressure, they have yielded sig-
nificant inverse correlation between PTT and systolic blood pressure, not diastolic 
blood pressure (Chen 2000; Zakaria 2010). According to Larkin (2005, p.35), Newlin 
(1981) disagreed that PTT presents the index of blood pressure. He had considerable 
evidence suggesting that it was more strongly linked to beta-adreneric cardiac activity 
than to blood pressure. Hey (et al. 2009) tells in his paper that with PTT one can get 
comprehensive information about cardiovascular state. It was noted that longer the 
length between heart and the PPG measurement point, for instance fingertip, the smaller 
are the error in time domain. This is one reason why the fingertip is most used PPG 
measurement point, although fingertip as a measurement point is more prone to error 
caused by movement. (Hey et al. 2009) 
 
According to various researches calculating PTT measurement has been started from the 
peak of ECG’s R wave (Chen et al. 2000; Hey et al. 2009; Ma & Zhang 2005; McCar-
thy et al. 2011; Zakaria et al. 2010). Some papers introduce that PTT can be calculated 
from the peak of ECG R-wave and to the peak of the PPG signal (McCarthy et al. 2011; 
Zakaria et al. 2010).  According to McCarthy’s (et al. 2011) investigation PTT meas-
ured from peak-to-peak shows good correlation with measured SPB with clinically vali-
date blood pressure measurement device. The mean difference between all the results 
for each of the volunteer was less than 3 mmHg. However, there was quite large stand-
ard deviation. It must be noted that blood pressure tracking was done using constant re-
calibration at 5 minutes intervals. Zakaria (et al. 2010) also measured SBP with PTT 
from peak of the ECG’s R wave to peak of the PPG wave. He claims that measuring 
PTT from peak of the R wave to the peak of the PPG-wave is widely accepted. Zakaria 
accomplished different experiments in only relax condition and in relax, exercise and 
recovery condition. The most accurate results were collected from an individual in three 
different conditions.  The result of investigation was that using the method to estimate 
SBP with help of PTT is achievable. (Zakaria et al. 2010) 
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Figure 10 shows the definition of pulse transit time in various studies. (McCarthy et al. 2011) 
 
Chen (et al. 2000) measured PTT from peak of R wave to the onset of PPG wave. He 
found reliable information that SBP changes can be extracted from the variation in pulse 
arrival time although it is not enough accurate to estimate absolute blood pressure. Chen 
speaks in his paper about pulse arrival time (PAT) instead of PTT. Many speak about 
PTT meaning same as Chen’s PAT. He divides pulse arrival time (PAT) consisting 
from two components: the isovolumetric contraction time or pre-ejection period (PEP) 
and pulse transit time (PTT). The contraction time is the interval during contraction of 
myocardium when intraventricular pressure rises sufficiently to open the aortic valve 
and push blood out of the ventricles. Chen explains that isovolumetric contraction time 
has been found to be sensitive to the sympathetic nerve system rather than blood pres-
sure. For instance some beta-adrenergic blocking agents have been found to reduce 
isovolumetric contraction time. He speaks that pulse transit time indicates the time de-
lay from aortic opening to the arrival of the blood pulse wave at peripheral vessels, 
which is inversely proportional to the pulse wave velocity.  As well, Chen determines 
that method is neither compatible to determine absolute blood pressure or detecting 
small changes of blood pressure but is compatible for monitoring blood pressure in long 
periods.  Chen proposes that to determine slow changes in blood pressure intermittent 
calibration measurement could be used when measuring SBP continuously. Chen pro-
poses that by integrating the estimation algorithm into an automatic system of cuff con-
trol a convenient non-invasive blood pressure monitoring system can be realized. In his 
research he examined 20 patients during cardiovascular surgery. The estimated values 
of SBP were compared with values measured invasively. The result showed the correla-
tion coefficient 0.97 ± 0.002 (mean ± standard deviation) and error remained with in 
±10% in 97.8 %. (Chen et al. 2000) 
 
Hey (et al. 2009) introduces that PTT can be determined by calculating the time differ-
ence between R-wave of the ECG signal and P-base point of the PPG signal. P-base 
point corresponds to the intersection point between the maximal slope during systolic 
rise phase and the horizontal line going through the point having the absolute minimum, 
introduced in figure 11. He explains that the main advantage of using the P-base point is 
that it guarantees a better noise and artefact robustness, because it is determined out of 
two characteristic points in the pulse wave. (Hey et al. 2009) 
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Figure 11 describe determination of the virtual base point or P-base point. (Hey et al. 2009) 
 
Hey (et al. 2009) suggests that due to physiological and anatomical limitations limi-
tation such as pulse wave velocity and length of blood vessel segment, the PTT is 
constrained to be in a defined interval, which he suggests to be 0,11- 0,475 sec-
onds.  In this calculation, he considers a minimal pulse wave velocity to be 4 m/s 
and maximal 20 m/s a minimal length of the measurement segment to be 0,2 m to 
1,5 m. In addition he estimates the maximal pre-ejection period (PEP) to be 0,1 s, 
which is compromised.  (Hey et al. 2009) This is harsh approximation but gives an 
idea of the length of the PTT.  
 
PTT is influenced by multiple physiological and anatomical factors, such as cardiac 
output, the elastic properties of arteries (arterial stiffness, arterial diameter), 
blood viscosity venous return and other cardiovascular variability’s (Ma & Zhang 
2005; Zakaria et al. 2010). The main difficulty of the method is that the elasticity of 
the vessel wall is not constant. It has been found to differ individually and is affect-
ed by neuro-humoral factors. It has been suggested that PTT might not be suffi-
cient to estimate absolute blood pressure. (Chen et al. 2000) Commonly PTT has 
been inversely related to systolic blood pressure. In papers of Zakaria (et al. 2010), 
Ma and Zhang (2005), they propose that it could be a good parameter to indicate 
blood pressure changes.  They present that PTT has been suggested as a non-
invasive and cuff less means for continuous blood pressure measurement in many 
researches. Ma and Chang (2005) present, same as Chen (et al. 2000), Zakaria (et al. 
2010) and McCarthy (et al. 2011), that short-term variability in PTT and blood 
pressures is expected to be highly correlated with each other in certain circum-
stances. Ma and Chang also explain that both blood pressure and PTT are im-
portant signs of cardiovascular circulation the association between the short-term 
fluctuations in them could also convey important information of regulatory mech-
anism within cardiovascular system.  In paper, they conclude that PTT is highly 
associated with blood pressure and can be potentially used for blood pressure var-
iability estimation for subject at static body state. Ma and Zhang (2005), Zakaria (et 
al. 2010), Chen (et al. 2000) and McCarthy (et al. 2011) states PTT is ideal for con-
tinuous 24-hour blood pressure measurement since it is both cuff less and non-
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invasive therefore comfortable and unobtrusive for the patient. 
 
Blood pressure is normally presented in millimetres of mercury (mmHg). Pulse arrival 
time in units of milliseconds tells a little for health care personnel who have not been 
engrossed with the matter. If blood pressure is presented using pulse arrival time it must 
be converted millimetre of mercury, which is more informative to health care personnel. 
Chen (et al. 2000) estimated blood pressure using pulse arrival time by using a sys-
tem with automatic cuff inflation and deflection to acquire intermittent SBP values.  
Chen (et al. 2000) concluded equation 13 by using pulse wave velocity, gravitation-
al properties and properties of vessel, blood and blood pressure.  
 
       
 
   
     (13) 
 
, where  Pe is estimated blood pressure 
Pb is base blood pressure 
γ is an elastic modulus coefficient of the vessels  
Tb is PTT value corresponding Pb 
 ΔT is changes in pulse arrival time 
 
According to Chen (et al. 2000) in equation 13 elastic modulus coefficient (γ) of the 
vessels ranges from 0.016 to 0.018 mmHg-1 what depends on the particular vessel. 
He claims that blood pressure estimation can be given during short period of time 
if the change in vessel elasticity is negligible. He adds that the coefficients should 
be determined by repeating the calibration and that coefficient are only valid if 
elasticity of the arterial walls stays constant. McCarthy (et al. 2011) used almost 
same formula as Chen (et al. 2000). 
3.3 Bioelectrical impedance 
 
The electrical bioimpedance (EBI) has many practical applications related to monitor 
physiological events. For instance, impedance plethysmography measures small chang-
es in electrical resistance in some regions of the body to asses changes in blood volume. 
Bioelectrical impedance analysis (BIA) makes use of EBI in the assessment of the 
amount of body water and body composition. (Blomqvist 2012) BIA is a simple inex-
pensive, quick and non-invasive technique for measuring body composition. (Muobarak 
2012) Impedance (Z) describes circuit’s property to resist electrical current (I) when a 
voltage (U) is over the circuit. Impedance describes relation of voltage and current with 
following equation: 
 
  
 
 
        (14) 
 
, where  Z is impedance 
 U is voltage 
 I is current 
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 R is resistance 
 X is reactance 
 
When considering alternating current (AC), the phase of voltage and current can be can 
be different. This is why complex values are used to present impedance. Electrical bi-
oimpedance (EBI) or bioelectrical impedance describes tissue’s property to resist elec-
trical currents. Biological tissue consists from cells surrounded by extracellular medi-
um. Cells are composed of several organelles and intra cellular medium enclosed by cell 
membrane. (Ruiz 2011, p.6)  Bioelectrical impedance analysis (BIA) allows the deter-
mination of fat-free mass (FFM) and total body water (TBW) in subjects without fluid 
and electrode abnormalities (Kyle et al. 2004).  The electrical impedance of the material 
is given by impedance times its shape factor. The shape factor depends on the length of 
the volume conductor and the available surface for the electrical current to flow. (Mar-
tinez 2007, p.22) The principle of bioelectrical impedance analysis (BIA) from human 
body can be described with help of a cylinder, in figure 12.(Kyle et al. 2004) 
 
Figure 12 shows the cylinder model from the relationship between impedance and geometry. (Kyle et al. 
2004) 
 
Kyle (et al. 2004) explains in his paper about the electrical properties of body that alt-
hough body is not a uniform cylinder and its conductivity is not constant, an empirical 
relationship can be established between impedance quotient and volume of water. Water 
contains electrolytes that conduct the electrical current through body.  The resistance 
(R) of a length of homogenous conductive material of uniform cross-sectional area is 
proportional to its length (L) and it is inversely proportional to its cross sectional area 
(A) described in equation 13. (Kyle et al. 2004) 
 
  
  
 
 
   
 
    (15) 
 
, where    is the resistivity of conductive material. 
 L is length 
 A is cross-sectional area 
 V is volume 
 
Due to body’s field inhomogeneity the equivalent cylinder model must be matched with 
an appropriate coefficient to real geometry. This coefficient depends on various factors 
and the anatomy of the segment under investigation. Other challenges are that in prac-
tice it is easier to measure height than conductive length and body has two types of re-
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sistivity to an electrical current: resistance and reactance. The capacitive resistance (re-
actance) arises from cell membranes and resistance from cellular fluids. There have 
been presented variety of cellular circuit models. Figure 13 demonstrates one of the 
most used simple equivalent cell circuit model, as well known as Fricke’s electrical 
model. The capacitive component (C) is related to bilayer of cell membrane (Ruiz 2011, 
p.6), sometimes presented as capacitive reactance (XC) (Kyle et al. 2004), Re is extra 
cellular water (mostly H2O-Na) and Ri intra cellular water (mostly H2O-K). (Ruiz 2011; 
Kyle et al. 2004) 
 
Figure 13 describe Fricke’s electrical model and circuit presentation on the right after simplification. 
Membrane resistance Rm is very small and thus disregarded. (Ruiz 2011 p.6; figure modified) 
 
From figure 13 can be seen that at zero or low frequency current does not penetrate cell 
membranes acting as insulator. Therefore the current passes through extra cellular fluid, 
which is responsible from measured R of total body resistance. Theoretically at infinite 
the capacitor behaves as perfect capacitor. Therefore the total body resistance represents 
both the extracellular and intracellular fluid (total body water, TBW). Since practical 
constrains prevent the use of direct current (DC) and infinite high frequency alternating 
current (AC), the R values for these frequencies are predicted using Cole-Cole plot pre-
sented in figure 14. (Kyle et al. 2004)  
 
 
Figure 14 presents Cole-Cole plot where phase angel’s (φ) relationship with resistance (R), reactance (XC) 
and impedance (Z) are presented.  (Kyle et al. 2004) 
 
There are several methods for bioelectrical impedance analysis (BIA). Considering this 
thesis it is necessary for reader to introduce single frequency BIA (SF-BIA) and multi-
frequency BIA (MF-BIA). SF-BIA is measured with single frequency, generally 50 
kHz. Electrodes are typically placed on the right hand and the right ankle. With single 
frequency it is not possible to measure total body water (TBW). With SF-BIA one can 
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have estimates from fat free mass (FFM) and TBW based on mixture of empirical theo-
ries. MF-BIA includes impedance in multiple frequencies. It uses empirical linear re-
gression models. It can be used to evaluate FFM, TBW, intra cellular water (ICW) and 
extra cellular water (ECW). At frequencies under 5 kHz and above 200 kHz poor repro-
ducibility of the measurements has been noted (Kyle et al. 2004). MF-BIA has proven 
to be less biased and more precise than the SF-BIA for extracellular fluid estimation but 
more biased and less precise for TBW estimation (Ruiz 2011, p.7-8).  According to 
Webster (2010, p. 372) the advantages of electrical-impedance plethysmography, mean-
ing in this case measuring volume changes, are that it is non-invasive and it is relatively 
simple to use. The disadvantages are that it is not sufficiently accurate for many of the 
attempted applications and that even the cause of the change in impedance is not clear 
in some cases.  Muobarak (2012) explains that BIA can be used for estimating overall 
survival of cancer patients. It also gives relevant information about FFM, body fat and 
body cellular mass. 
 
 
Figure 15 a two-electrode bioelectric impedance instrumentation setup. In figure Zep is sensing electrode 
polarization impedance, VTUS is measured voltage in tissue under study and ZTUS its impedance and Vm 
measured voltage. (Martinez 200,7 p.32, figure modified) 
 
EBI measurement is performed measuring the current generated by a known voltage 
applied on the tissue. The voltage is measured with differential amplifier. In the two-
electrode configuration the same two electrodes are used to current injection and for 
sensing of resulting voltage signal. The main drawback of two-electrode instrumenta-
tion setup is that the same two electrodes are used for electrical current injection and 
sensing resulting voltage. The voltage generated by the electrode polarization imped-
ance (Zep), in figure 15, is included into the voltage measurement. It cannot be distin-
guished. The voltage has been generated by current flowing through tissue or by the 
current flowing across the skin-electrode interface. Equations from 16 to 19 show the 
influence of the electrode polarization impedance (Zep) on the calculations of the meas-
ured impedance (Zm) from the measured voltage (Vm).  (Martinez 2007 p.32; Ruiz 2011 
p. 9) 
   
  
  
    (16) 
 
, where   Zm is measured impedance 
Vm is measured voltage 
Im is measured current 
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                           (17) 
 
, where  VTUS is measured voltage 
 Vep is electrode polarization voltage 
 
             (18) 
 
, where  Zep is electrode polarization impedance 
 
   
         
  
            (19) 
 
, where  ZTUS is impedance in tissue under study   
 
 
Figure 16 presents a four-electrode bioelectric impedance instrumentation setup. In figure Zep is sensing 
electrode polarization impedance, VTUS is measured voltage in tissue under study and ZTUS its impedance 
and Vm measured voltage. (Martinez 2007, p. 32, figure modified) 
 
In the four-electrode model, presented in figure 16, the current injected and response 
measured is done with two different electrode pairs. One electrode pair (Zep1) is used to 
lead the current to the tissue under study, while second pair of electrodes (Zep2) is used 
to measure the voltage over tissue under study (VTUS). With this configuration the volt-
age generated of the injecting leads (Zep1) does not affect the voltage measurement. 
Considering equations 18 and 19 and that the current (Iep) flowing through the measur-
ing electrodes is zero, when Vep comes to zero, then the impedance measured (Zm) is the 
impedance under study, presented in equation 20. (Martinez 2007 p. 32; Ruiz 2011 p. 9-
10) 
   
         
  
        (20) 
 
, where  Zm is measured impedance 
 VTUS is measured voltage 
Vep is electrode polarization voltage 
Im is measured current 
ZTUS is impedance in tissue under study 
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According to Ruiz (2011, p.11-12) bioelectrical impedance can be affected by several 
other errors. There might occur unwanted capacitance in the measurement system, 
which will increase sensing electrode polarization impedance between sensing elec-
trodes. These capacitances may come from capacitance between electrode leads, be-
tween body limbs and earth or between leads and ground. Effects of these capacitive 
leakages are small at low frequencies but can cause a tail or hook at high frequencies to 
Cole-Cole plot.  
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4 First pilot 
4.1 Aim of the first pilot 
The first pilot design was implemented to test the measurement devices compatibility to 
intended use.  First pilot design worked as test platform during the whole process to test 
the measurement on by one in a health chair concept. The aim was to evaluate function-
ality of the chosen measurement modules and to assure that called measurements could 
be done. At this stage, it was important to evaluate the reproducibility and repeatability 
of the constructed pilot as a product. Following measurements were implemented: 
 
 Electrocardiography (ECG) 
 Heart rate (HR) 
 Photoplethysmography (PPG) 
 Partial oxygen saturation (POX) 
 Electrical bioimpedance (EBI) 
 Weight 
4.2 Outlines of the first pilot 
To better the patience comfort and to fasten ECG measurement, it was implemented 
with dry electrodes. Measurement points were at the hands and wrist of the patient. 
Then there was not need to fix electrodes on body and only pre-measurement needed 
would be rising of sleeve.  Like Lim (et al. 2006) explained that although fixed-on-skin 
electrodes are reliable and give good signal quality they are inadequate and incompati-
ble for long-term everyday measurements. Skin electrodes were incompatible solution 
because of necessary fixation on the body surface and their usage would also extend the 
pre-measurement time. To evaluate the measurements compatibility fixed-on-
environment electrodes were chosen. In this case electrodes were integrated to chair 
armrests. Dry-electrode measurement was tested on first pilot design, but implemented 
only to third pilot design. Other limit to pilot design was not seen necessary. 
4.3 Realization of the first pilot 
Realization of first pilot design was made on wooden chair. Each module was attached 
on chair and tested one by one. On each commercial module LabVIEW program was 
made. Bioelectrical impedance module was tested with its own available program. All 
the testing of modules and implemented programs is explained in following chapters.  
 
Instrumentation of electrocardiography measurement was made on EMB1 board and its 
available starter kit. Both are products of Corscience (Corscience EMB1 2010). Module 
was compatible to patient monitoring with only necessary of 1-channel and four lead 
lead electrodes from which two were measurement electrodes. It also included real-time 
R wave trigger via hardware or communication protocol. There it could be synchronized 
to cardiac cycle from where pulse transit time could be measured. Testing of ECG mod-
ule was made first with Ag/Ag-Cl skin electrodes. After receiving satisfying signal dry-
electrodes made from stainless steel were used. 
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A pulse oximeter board ChipOx made by Corscience was chosen because of its low 
current consumption, which would make it compatible for battery operation.  It also 
included output of raw plethysmograph signal in real-time, which would make compati-
ble for pulse transit time analyses. (Corscience ChipOx 2010)  Options for PPG and 
partial oxygen saturation measurements were fingertip or earflap. Those are two most 
traditionally used measurements. The fingertip measurement was chosen. According to 
Espina’s research earflap measurement is less prone to motion artefacts and hydrostatic 
variation and more patients comfortable in long time measurements (Espina et al. 
2006). We concluded that earflap measurement was incompatible for our needs. PTT 
measurement was wanted to be accurate. The measurement time on health chair would 
be measured in minutes. Earflap measurement would possibly require removal of ear-
ring.  Earflap measurement is as well more prone to loose signal when patients suffer 
low blood pressure, which must be taken in consideration when measuring elderly peo-
ple. Also, earflap measurement was estimated to lower patient comfort. Moyle (2002) 
tells that changes in pulse pressure during induction, maintenance and recovery from 
anaesthesia are greater when recorded from finger than from ear. He as well recom-
mends monitoring PPG from finger whenever it is possible to gain the greatest amount 
of clinically useful information. (Moyle 2002, p. 56It should be noted when determining 
patient systolic blood pressure with pulse transit time method that the bigger the dis-
tance between PTT measurement point and the heart is, the less impact mistaken meas-
urement values in time domain has on the PTT determination. (Hey et al. 2009) For this 
reason the pulse wave was detected from fingertip. Instrumentation of photoplethys-
mography and pulse oximeter was made on ChipOx miniaturized pulse oximeter mod-
ule and to its development kit (Corscience ChipOx, 2010).   
 
An open-source hardware module OpenEBI designed in Aalto University by Blomqvist 
was chosen to analyse electrical bioimpedance. The availability of commercial EBI ana-
lysers was limited. This module was easily available and knowledge and experience 
from it was well known. As well, setting up and validating commercial EBI measure-
ments were estimated to be time consuming. The module uses four-electrode multi-
frequency measurement. MF-BIA measurement was obligatory that total body water 
and fat free mass could be measured. Four-electrode measurement was necessary to 
avoid the influence of the voltage generated by the electrode impedance. (Blomqvist et 
al. 2012) Testing of the openEBI module was executed and Cole-Cole plot, presented in 
figure 14, was drawn. At this stage, further investigation was not made. 
 
Weight measurement was made with sensors taken from commercial weight scale. The 
possible inaccuracy with weight-scale-sensor measurement was well known, but as ex-
plained previously the aim of first pilot design was not to make as accurate measure-
ment as possible. The sensors were placed on the bottom of the legs of the chair. Output 
current changes were observed with multi meter when weight was added. At this stage, 
further investigation was not made. 
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4.4 Software of the first pilot 
Software interface between electronic modules and computer was implemented with 
LabVIEW (short for Laboratory Virtual Instrument Engineering Workbench). It is a 
design platform and development environment designed by National Instruments. 
LABVIEW is a graphical programming platform commonly used for data acquisition, 
instrument control and industrial automation. LabVIEW creates development systems 
and user interface, which are called front panels in the program. LabVIEW programs 
are called virtual instruments (VI’s). Each VI consists from user interface and block 
diagram. Every user interface works in parallel with block diagram, which includes 
terminals, functions, constants, structures etc.  Each virtual instrument can include vari-
ous other virtual instruments when they are called sub virtual instruments (subVI’s). 
(National Instruments 2013) 
 
The communication protocol of ECG module EMB1 used point-to-point protocol (PPP). 
To filter out reserved bytes such as start flag, end flag and escape flag from data steam 
extra escape flags are used. This is also called octet stuffing. The octet stuffing in the 
transmitter occurs after the checksum calculation.  For the checksum formation in the 
transmitter the start and end flag was not included. In the receiver, inverse octet stuffing 
was applied first, before the data stream is saved or further processed. In the receiver, 
the checksum algorithm is run over an entire packet, and then result must be zero. 
(Corscience EMB1 2010, p. 16) 
 
Table 1 presents EMB1 packet structure and descriptions of individual fields (Corscience EMB1 2010, p. 
16) 
Start flag Packet number Command Payload Checksum End Flag 
0xFC 1 Byte 2 Bytes x Bytes 2 Bytes 0xFD 
 
EMB1 packet structure and individual fields are described in the table 1 above. Three 
special characters may not appear by accident in the packet: 
 
 Start flag 0xFC 
 End flag 0xFD 
 Escape flag 0xFE 
 
If one of these characters appeared in the data stream an escape flag is send first and 
then the original byte is linked with 0x20. 
 
Table 2 describes data packet octet stuffing (Corscience EMB1 2010, p.17) 
Characters within the packet Are changed to the following when sent 
0xFC 0xFE 0xDC 
0xFD 0xFE 0xDD 
0xFE 0xFE 0xDE 
 
The packet number has a length of one byte and therefore sweeps through number 0 to 
255, once 255 is reached the next packet start again with 0. The packet numbers are 
numbered so that missing packets can be detected, received packets can be confirmed, 
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undesired packets can be rejected and defective packets can be resent. The Command 
field is two bytes long and contains the command least significant bit (LSB) first. Pay-
load includes the actual data to be transmitted. Checksum has a length of two bytes. The 
parameters of checksum are:  
 
 CRC16 (CCIITT) 
 Polynomial 0x1021 
 Start value  
 0xFFFF LSB first 
 
The checksum is calculated in the transmitter over the entire packet with the exception 
of the start flag, end flag and checksum. The checksum must be calculated in the trans-
mitter before octet stuffing. In the receiver, the checksum is calculated over the entire 
packet with the exception of the start flag and the end flag. For valid packet the result 
must be zero. The checksum test must be carried out after octet stuffing. (Corscience 
EMB1 2010, p. 17) 
 
Figure 17 presents EMB1 LabVIEW VI hierarchy. 
 
Implemented program is described in block diagram in figure 15 and explained with 
help of block diagrams in appendix 1. EMB1 module interface was designed so that the 
module would be found despite of various other devices and automatically with no need 
for the user to participate in finding the module. Finding EMB1 serial port was done in 
EMB1 request ID subVI, in figure 17. In this subVI it was necessary to send Identifica-
tion Inquiry command to check that program has identified right device. 
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The subVI called CRC16 CCIITT to calculate the correct checksum over entire packet 
with the exception of the start flag, end flag and checksum. The checksum was neces-
sary to calculate when commands were send from computer program to EMB1 module. 
Algorithm can be expressed in following way (National Instruments 2010): 
 
int x; 
x = ((crc>>8)^data) & 0xff; 
x^=x>>4; 
crc=(crc << 8)^(x<<12)^(x<<5)^x; 
crc &= 0xffff;  
 
Main task of Protocol Analog Request subVI was to send Protocol Version Inquiry 
Configure Analog Request command, which was necessary to ECG module. Protocol 
Version Inquiry commands inquired the protocol version of the EMB1 module. This 
was done to assure that correct device was found among other devices. Configure Ana-
log Request command configured the wanted sampling rate to 1 kHz, active ECG chan-
nels to one and used mains frequency of 50 Hz. The configuration of main frequency set 
the filter for internal QRS-wave detection algorithm. It was not used to filter the mains 
frequency out from ECG data stream. (Corscience EMB1 2010, p.31) 
 
The reading of serial ports and data sent from EMB1 to computer was made on EMB1 
VI. Start ECG Transmission and Stop ECG Transmission commands were send in this 
virtual instrument. R peak detection was made in this VI from where RR time interval 
was calculated. Both heart rate in beat per minute and ECG signal was served for user 
from this VI.  
 
The ECG data send from EMB1 to program and finding of packet structures, presented 
intable 1, unpacking the octet stuffing and serving of QRS wave detection index to 
EMB1 VI were made on Decoding ECG Signal VI. This VI searched one packet struc-
ture with help of start and end flag. It unpacked octet stuffing in inverse way than pre-
sented in table 2. 
 
Unpack ECG VI unpacked the ECG payload from ECG data packet structure. ECG pay-
loads were packed so that if only 7 bits within a data value was used EMB1 packed the 
15 bit value to 7 bits value which was necessary to convert pack to 15 bits value in to 
draw ECG signal for user monitor. Distinguishing between one and two byte values was 
made with mask bit. (Corscience EMB1 2010, p. 29) Unpacking these values is de-
scribed more precisely in appendix 2. 
 
ChipOx pulse oxymetry module LabVIEW program was designed in a way that it could 
find the module despite of multiple devices. In figure 17 VI hierarchy of ChipOx pro-
gram is presented. ChipOX GUI VI describes of ChipOx user interface. ChipOx  GUI 
VI, described in appendix 2, made data handling and draw the wanted signals for user. 
VISA (Virtual Instrument Software Architecture) serial box describes serial port com-
munication between device and computer. 
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Figure 18 presents VI hierarchy of ChipOx LabVIEW user interface.  
 
ChipOx program’s block diagram is presented in appendix 2.Module was found auto-
matically in Find ChipOx VI by identifying from the data stream hexadecimal charac-
ters A8 and 7F, which are 168 and 127 in decimals. Module started to measure PPG 
directly when switched on. ChipOx packet structure is presented in table 3. (Corscience 
CipOx 2010, p.23) 
 
Table 3 presents data packet structure of ChipOx module and clarifies meaning of it parts. (Corscience 
ChipOx 2010, p.23) 
Start Flag Data Checksum Flag 
 
Identifier: Description: Size: 
Start Flag: Beginning of packet 0xa8 1byte 
Data: Data packets Variable 
Checksum: Checksum from all Data field 2 bytes 
End Flag: End of the packet 0xa8 1 byte 
 
Module sent data packet consisting from data, checksum, start and end flag using byte-
stuffing algorithm. According to manual the purpose of the stuffing is to detect packets 
securely without losing the synchronization due to extraneous traffic. Reserved values 
was in hexadecimals 0xa8 (in decimals 168) used in start and end flag and secondly 
0xa9 (in decimals 169) use as control byte. If in the block of data or checksum a charac-
ter appears, which was 0xa8 or 0xa9, it was coded with following two bytes: 
 
 0xa8 is coded as 0xa9, 0x88 (in decimals 169, 136) 
 0xa9 is coded as 0xa9, 0x89 (in decimals 169, 137) 
 
The decoding of the communication protocol was done in the Decode ChipOx VI pre-
sented in appendix 2. The serial UART protocol of ChipOx is divided into communica-
tion layer and transfer layer. The communication layer is one layer above the transfer 
layer. It is completely contained in the Data-block of the transfer layer. (Corscience 
ChipOx 2010, p.22-23) 
31 
 
 
 
 
Table 4 presents communication layer is completely contained in Data-block in transfer layer. 
(Corscience ChipOx 2010, p.24) 
Transfer layer: Flag Data Checksum Flag 
or: Flag Data Channel-ID User Data Checksum Flag 
 
Decoded data channel-ID was 0x7F (127 in decimals) searched in Decode ChipOx- VI. 
Photoplethymography, blood oxygen saturation and pulse acquisition was made from 
real-time data channel marked with identifier 0x51 (in decimals 81). It was found from 
User Data- block right after data channel-ID. Character 0xa9 and 0x88 were decoded to 
0xa8, as well 0xa9 and 0x89 was decoded to 0xa9. After decoding PPG signal was 
drawn and pulse and blood oxygen saturation was presented. (Corscience ChipOx 2010, 
p.24) 
4.5 Discussion on the first pilot 
It was well known and noted that the stainless steel dry-electrodes used in the test ECG 
measurement would give noise.  Malmivuo and Plonsey (1995) noted that distortion 
adding factors in ECG measurement are muscular activity, respiration and electrode 
artefacts due to perspiration and electrode movement. One source of distortion was not-
ed to come from skin-electrode contact. Chi (et al. 2010) wrote in his paper that relative 
motion of electrodes with respect to body give rise to artefacts in the received signals 
that are one of the main impediments against the acceptance of dry-electrodes. These 
artefacts arise in low-resistance wet-contact electrodes as well. They can be reduced, but 
not eliminated, by careful mechanical design. (Chi et al. 2010) In addition, one noise 
source could be that the measurement points where at the wrists and palms. To keep the 
speed and easiness of ECG measurement, points were not changed. Large motion arti-
facts on dry electrode surface resulted in loss of the signal. Chair handles provoked to 
squeeze the sensor parts. Squeezing added more base distortion to signal because of 
electromyography. ECG distortion removal was important for the next pilot designs. In 
case of monitoring ECG, the distortion factor was tried to be minimize.  Due to poor 
ECG signal, estimating of blood pressure with pulse transit time method was dropped 
out from next pilot design. ECG signal removal was seen to demand more time than 
available before next pilot design would have to be in test stage. Other measurements 
were seen to be compatible for next pilot design. 
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5 Second pilot 
5.1 Aim of the second pilot 
Second pilot was designed for patient monitoring use to test the concept of health chair. 
Concept testing was necessary to see would health chair replace single traditional meas-
urement devices, for instance blood pressure. Also, feedback from concept of combin-
ing measurements devices to one health chair was welcome.   Aim of second pilot de-
sign was to make health chair, which would measure patients: 
 
 Blood pressure 
 Weight 
 Bioelectrical impedance 
 Blood oxygen saturation 
 Heart rate 
 Photoplethysmography 
 
Each measurement device would be merged to the chair. Nurses could execute tests in 
nursing home. For this reason measurements were chosen to be traditional and familiar 
to nurses.  This was one the reasons why pulse transit time measurement and ECG were 
dropped out for this pilot stage. Traditional measurements are familiar to nurses. By 
uniting the measurement to one single chair it would test if the chair would replace tra-
ditional measurement devices and in general be in nursing use. Design of the health 
chair was aimed to be patient comfortable.  Aim was to combine measurement module 
to typical couched armchair. 
5.2 Outlines of the second pilot 
To test the health chair concept in nursing home, the measurement devices were limited 
to traditional type of measurements. To see the acceptance of healthcare personnel was 
important, which limited the chosen measurements. Blood pressure measurement with 
cuff, PPG, blood oxygen saturation, weight and pulse rate were considered to be tradi-
tional and well-known measurements. Bioelectrical impedance was not considered as 
well known or traditional.  It was added to see acceptance of healthcare personnel and 
to consider if it would be fasted to next stage pilot.  
5.3 Realization of the second pilot 
Chosen blood oximeter device in second pilot was pulse oximeter board EG00352 and 
its test kit made by Medlab were chosen, because of it were able to operate with 3,3 V 
when needed power was easy to provide. It also operated with clear serial transmission 
protocol   (Medlab EG00352 2012). Also, there was in-house experience from module 
made by Medlab. This pulse oximeter measured wanted photoplethymography, heart 
rate and blood oxygen saturation. Data was transmitted with Universal Serial Bus 
(USB).  Supply voltage was provided from 3,3 V supply voltage pin from Arduino Uno. 
Data was conducted to USB hub with USB–to-serial converter. 
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Blood pressure was measured with NIBScan, a noninvasive blood pressure measure-
ment device made by Medlab, and its test kit. The NIBScan module uses oscillometric 
method for measuring blood pressure. It calculates pulse rate, and mean, systolic and 
diastolic blood pressures. Supply voltage of 15 V was provided with external medical 
grade power supply and regulator coupling. Data was translated to USB hub with USB–
to-serial converter. (Medlab NIBSCAN 2012) 
 
The weight was measured with sensors taken from commercial weight scale. Sensors 
were attached to four points between chair legs and frame holding the wheels. Sensor 
data was conducted to amplifier coupling made from INA122P instrumentation amplifi-
er (Texas Instruments 2000). Measured analog signal was conducted through low pass 
RC-filter to Arduino Uno board (Arduino 2011).  Here the analog signal send by the 
sensors was converted to digital signal. Small program was produced to send necessary 
weight data from Arduino to personal computer. USB was used to conduct data from 
Arduino to PC. Small tests were conducted to discover that weight measurement system 
correlated linearly with the added weights.  
 
Bioelectrical impedance module was added to chair and operation voltage was provided 
from USB bus, which was used to conduct data as well. EBI was measured with sensors 
made from stainless steel. These sensors were attached to armrests of chair. Four meas-
urement points were from left and right palm and wrist. The connected sensor module 
inputs were:   
 
 Left palm to I+ input  
 Right palm to I- input  
 Left wrist to V+ input  
 Right wrist to V- input  
 
Realized health chair pilot is presented in figure 19 where blood pressure cuff and pho-
toplethysmography finger clip can be seen hanging on the right armrest. Four stainless 
steel sensors are clearly detectable on hand rests. User monitor is clearly detectable on 
the chair. Block diagram of connected modules, kits, connections and other devices is 
presented in appendix 3. 
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Figure 19 presents second stage pilot design. Blood pressure cuff and photoplethysmography finger clip 
can be seen hanging on the left armrest. Stainless steel sensors and user monitor are clearly detectable. 
5.4 Software of the second pilot 
Pulse oximeter board EG00352 provided two separate serial transmission protocol from 
which serial transmission protocol version two was used. The second protocol imple-
mented the same functionality as the first one without the large redundant data overhead 
of the first variant. Plethysmographic waveform data was send with 50 Hz transmission 
rate. According to producer, this transmission rate was used because higher frequencies 
did not produce smoother waves, and lower frequencies would lead to incorrect impres-
sion of the waveform. (Medlab EG00352 2012, p. 10) 
 
In this transmission protocol a block with new saturation value, pulse rate and perfusion 
index info is transmitted on each detected pulse. The pulse wave sample points were 
transmitted continuously 50 samples per second. Their values were located between 0 
and 247 (0xF7 in hexadecimals).  Byte values larger than 0xF7 were used for marking 
the next byte in the stream as a new value. Definitions of marker bytes are presented in 
table 5. (Medlab EG00352 2012, p.10) 
  
35 
 
 
 
Table 5 presents definitions of the marker bytes in EG00352 (Medlab EG00352 2012, p. 10) 
Marker byte: Meaning of the following: 
0xF8 Wave sample points follow. 
0xF9 SpO2 value follows. 
0xFA Pulse value follows. 
0xFB Info byte follows. 
0xFC Quality and Perfusion index follows. 
 
Programs for EG00352 plethysmograhic module were implemented with LabVIEW 
programming environment.  Two virtual instruments EG00352 virtual instrument and 
Find POX virtual instrument were implemented. Their block diagrams are presented in 
appendix 4. EG00352 VI was implemented so that Find POX- virtual instrument would 
automatically search and connected EG00352 device to computers serial port. Find 
POX would provide the serial port to EG00352 VI. VI hierarchy can be seen in figure 
20.  
 
Figure 20 presents VI hierarchy of EG00352. Figure clarifies functioning of EG00352 and Find POX VIs 
 
In EG00352 virtual instrument, communication protocol used by PPG module was un-
packed. Appendix 4 introduces central part of EG00352 virtual instrument. This VI 
drew all the photoplethysmographic values, following byte 0xF8 (248 in decimals), to 
graphical user interface. This part also showed for the user SpO2 value following byte 
0xF9 and pulse value after 0xFA. Byte after 0xFC described quality and the perfusion 
index. This part also evaluated the situation in PPG finger probe, from bytes after the 
info byte 0xFB.  The following bytes in order described: 
 
 0x00: OK 
 0x01:  Sensor disconnected 
 0x02: No finger in probe 
 0x03: Low perfusion 
 0x2d: Self-test error 
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Blood pressure was measured with chosen non-invasive blood pressure NIBPScan 
module. Host controlled the measuring unit via command frames according to its trans-
mission protocol. All data and commands were verified by checksum. Start and end 
flags were used to separate data strings.  ASCII (The American Standard Code for In-
formation Interchange) character 02 presents start flag and ASCII character 03 present-
ed end flag. Software interface commands consisted of an eight ASCII character frame 
presented in table 6.(Medlab NIBSCAN 2012, p. 6) 
 
Table 6 presents NIBP’s eight ASCII frames (Medlab NIBSCAN 2012, p.6) 
Char 1 Char 2 Char 3 Char 4  Char 5 Char 6 Char 7 Char 8 
STX c0 c1 ; ; x0 x1 ETX 
Start  Command 
code 
Command 
code 
Semicolon Semicolon Checksum Checksum End  
 
In each command existed codes: start of text, end of text, two semicolons and check-
sum. The checksum is presented with two ASCII characters and it was generated from 
by modulo 256 addition of all characters in the corresponding frame, without start and 
end flag. (Medlab NIBSCAN 2012, p.6) 
 
In figure 20 virtual instrument block diagram is presented. To clarify function of NIBP 
VI and Find NIBP VI block diagram is presented in appendix 5. NIBP VI got serial port 
from Find NIBP VI. The latter VI was designed to find NIBP module from serial port 
despite of various other devices.  
 
Figure 21 presents NIBP VI block diagram. 
 
NIBP VI received resource, in this case serial port, from Find NIBP VI. Program waited 
till user pushed Start Measuring-button, when it automatically selected adult measuring 
mode and send Start Measuring-command. While measuring, temporal cuff pressure 
was measured and possible errors were analysed. End of measuring was detected if no 
bytes were detected in 300 ms. Cuff pressure was sent 5 times per second (Medlab NIB-
SCAN 2012 p. 9).  After the measurement end, cuff pressure transmission was read. 
Then Read Status from Slave command was send when module send previously meas-
ured heart rate and diastolic and systolic blood pressure could be read. 
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Bioelectrical impedance was measured with openEBI measurement module (Blomqvist 
2012). Appendix 6 describes functioning of virtual instruments Z and Find Z. Function 
of Find Z VI was to find module from various other devices connected to measurement 
computer.  Find Z VI sent to opened serial port ‘s’ command, which worked as start 
measurement command for openEBI. After sending the command serial port was read 
and regular expression for openEBI was recognized and serial port was send forward. 
Figure 22 describes the functioning of virtual instruments.  When serial port of openEBI 
was found, ‘s’-command was send again. Serial port was read and received string was 
ensured to belong to openEBI by recognizing character ‘$’, which was last element of 
string.  From this string “abbc-(b+)=ac” VI changed each ‘\.’ to ‘,’ to clarify the decimal 
values. Each impedance value was complex number from which absolute values were 
calculated. Values were drawn to XY graph and mean value was calculated to present 
one impedance value for user.  
 
 
Figure 22 represents VI hierarchy of electrical bioimpedance measurement. 
 
Weight measurement was executed with Arduino Uno board, weight measurement sen-
sors and amplifier coupling. A LabVIEW program was executed with tree virtual in-
struments: Find Weight VI, Weight VI and A/B xtrac VI. To clarify functioning of vir-
tual instruments block diagram is presented in appendix 7. Figure 23 presents VI hierar-
chy diagram of weight measurement program. Purpose of Find Weight VI was to find 
Arduino Uno board, which was connected between weight measurement sensors, ampli-
fier coupling and computer. Appendix 3 clarifies connections made. Arduino was iden-
tified with regular expression: “-Arduino-”. A small Arduino sketch was realised with 
Arduino Development Environment (Arduino 2013). The board was programmed to 
send the regular expression to help to identify the board among other devices. Find 
Weight VI send the serial port found to Weight VI. Weight VI read the serial port and 
sent found port too A/B xtrac VI. This VI found expression ‘W’ from received string. If 
expression ‘S’ was found weight was simulated. This part was done to present the func-
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tioning of whole graphical user interface for user during development of weight meas-
urement. It was not used after weight measurement was carried out with sensor data.  
When expression ‘W’ was found weight data was send to Weight VI. Weight VI 
showed raw body weight data to user. Raw body weight data presented amplified signal. 
It was translated to kilograms with help of constant and body weight coefficient. The 
body weight of the patient was determined by calculating mean value from 25 different 
values from calculated body weight. 
 
Figure 23 presents VI hierarchy of weight measurement program. 
 
After implementing previously mentioned module interfaces, building of coherent sys-
tem was started. The system included the module interfaces of NIBP, EG00352, Ar-
duino Uno and EBI modules. When the program was started Arduino Uno module was 
found first after that in order EBI, POX and NIBP modules were found. If some of these 
modules were not found user of the program was asked, that some measurement mod-
ules have not been found. Possibly a new research was conducted if user chose so. Fig-
ure 24 clarifies initializing of measurements. If some module was not found the possi-
bility was to choose to insert 0 to measurement or to simulate it. The procedure was 
done by providing possibility to execute measurements despite modules were missing. 
Simulations of measurement were used when user interface was tested. The possibility 
to simulate measurements was left to this pilot stage to introduce the function of graph-
ical user interface during development and maintenance of modules. 
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Search for modules.
Is there missing 
modules?
Search again?
Yes
No
Yes
No
Set measurement 
to 0?
Simulate 
measurment?
No
Simulate 
measurement.
Shut down program.
Go to measurment 
tab.
Set measurement 
result to 0.
Yes
No
Yes
 
Figure 24 presents block diagram, which clarifies initializing of measurements. 
 
When measurement procedure was started the program wanted to confirm that nurse 
had done obligatory tasks in order:  
 
1. Client is seated 
2. Blood pressure cuff is placed 
3. Blood oxygen saturation sensor is placed 
4. Palms are placed on the sensors 
5. Legs are raised to footrest 
 
After confirming these procedures the measurements could be started. The sitting of the 
client was confirmed when adjustable weight sensor threshold value was exceeded. 
Taking a test measurement ensured that blood pressure cuff was placed. The procedure 
took two to three minutes and took most of the time of the whole verification. For this 
reason during cuff measurement other measurements were ensured. This verification 
was run in parallel with others. Placement of blood oxygen saturation finger clip senor 
was ensured with help info byte from the module. EBI measurement was confimed by 
placing the palms placed on the impedance measurement sensors. The verification was 
done measuring increasing impedance, while measurement frequency was increased.  
This threshold was placed when absolute value of third measurement frequency was 
larger than thirtieth. Electrical bioimpedance was measured with 49 different frequen-
cies (Blomqvist 2013).  Confirming that legs were raised on the footrest was left on re-
sponsibility of nurse. This measurement was not assured in anyway. The purpose of the 
question was to remind the nurse from it.  When measurements were started they were 
processed in same order as in test stage.  
 
There were different operators installed to health chair system. Installed prime operators 
in program were guest, admin and master. The guest was only able to make measure-
ments, which were not recorded for later use. The admin was able to make measure-
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ments and to add and remove users. These users were able to add clients and make 
measurement, which were saved for later monitoring use.  Measurements, which were 
done under admin user, were recorded for later use.  The master user was able to add 
and remove users and admins. He was also able to make measurements, which were 
recorded. Table 7 clarifies what each profile could do. Password was required from each 
user, despite guest. The password was set when first login into the profile was done. 
 
Table 7 presents requirements and possibilities of each profile 
 Guest: User: Admin: Master: 
Make measurement: Yes Yes Yes Yes 
Add/remove user: No No Yes Yes 
Add/remove client: No Yes No Yes 
Add/remove admin: No No No Yes 
Password required: No Yes Yes Yes 
 
Priorities of second stage pilot design graphical user interface were ease of use and 
clearness of monitored measurements. Figure 25 clarifies the start page in the program 
where measured parameters can be seen. In each tab, for instance body weight (BW), 
history of each measurement could be monitored. Exception tabs were SpO2 tab were 
the current photoplethysmography signal could be seen and Settings tab were user could 
change for instance weight measurement threshold. 
 
 
Figure 25 presents main page shown for user. Measurement tabs can be seen under text where infor-
mation for user is shown. 
5.5 Discussion on the second pilot 
The pilot was implemented to discover that all the integrated measurement could be 
conducted in one health chair. The pilot showed this to be achievable as expected. Some 
issues should be improved, for instance occasionally tale was formed after drawn Cole-
Cole plot. As explained previously, tale could be formed from unwanted capacitance. 
This can rise from increased sensing electrode polarization impedance between sensing 
electrodes and from improper adjustment of EBI module. The module was designed to 
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measure from abdominal with wet-gel electrodes, not with dry electrodes.  As Ruiz 
(2011) explained these capacitive leakages are small at low frequencies but can cause a 
tail or hook at high frequencies to Cole-Cole plot. Other notable improvement should be 
done to weight measurement system. With proper adjustment of the linearity factors 
correct weight was measured but measurement were not been able to conduct from day 
to day without proper adjustment. During the thesis the second pilot design was tested 
in nursing home. The health chair was used and concept was seen useful.  
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6 Third pilot 
6.1 Aim of the third pilot 
Health chair’s third pilot design was one step forward to dry-electrode measuring.  The 
aim was to test the measurements designed and conduct them to their final state. The 
aim of the third pilot was to verify the applicability of dry-electrode ECG signal meas-
urement and also RR and QT intervals measure from it. The aim was also to verify the 
applicability of the blood pressure estimated from pulse arrival time to blood pressure 
estimation. This thesis introduces testing of RR and QT interval estimation and blood 
pressure estimation from PTT in later chapters. The aim of the pilot was also to contin-
ue testing of these measurements and health chair concept after the thesis.  The third 
pilot was not finished during this master’s thesis. The third pilot design was aimed to 
measure patients: 
 
 Electrocardiography 
 Weight 
 Bioelectrical impedance 
 Blood oxygen saturation 
 Hear rate 
 Photoplethysmography 
 Pulse transit time and estimate systolic blood pressure from it 
 
Each measurement device would be merged under the chair and so they would be not 
clearly detectable. In this stage ECG measurement with RR and QT interval analysing 
was included. Also, patient blood pressure would be possible to estimate with pulse 
transit time method. Design of the health chair aimed to be patient comfortable.   
6.2 Outlines of the third pilot 
Limiting factors on third pilot design were that amount sensors attached to the skin sur-
face of patient should be minimized. Design would be made in patient comfortable 
manner. The health chair would be built to typical couched armchair.  ECG would be 
measure with the dry-electrodes instead of skin attachable wet electrodes to maximise 
fast and easy measurement. The measuring OEM modules were limited to modules al-
ready chosen to previous pilot designs. Blood pressure would be estimated with pulse 
transit time method in which ECG and pulse oximeter modules would be used. PPG 
wave would be measured from the fingertip of the patient. With fingertip measurement 
PTT is less prone to errors, because distance between heart and measurement point is 
longer, than in earlobe or nose clip measurements.   
6.3 Realization of the third pilot measurements 
Deployment of EMB1 ECG module started in first pilot with attaching skin electrodes 
and implementing small LabVIEW program. First test were conducted with skin elec-
trodes. In this stage some distortion was noted in ECG signal.  After this stage on third 
pilot stage digital filters were added to program.  A fourth order bandstop Bessel filter 
was added to frequency range of 49-51 Hz to bloc distortion from mains frequency. A 
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second order lowpass inverse Chebysev filter with 30 dB attenuation was added to limit 
the frequency range to 150 Hz. According to Webster (2011, p. 253), ECG’s upper cut-
off frequency can be set to 150 Hz. EMB1 module included software baseline filter. 
This baseline filter used 0,3 Hz filtering 2,65 seconds after starting ECG transmission to 
ensure fast recovery time of the baseline. After this time baseline filter of 0,05 Hz was 
used to ensure not disturbing ST segment.  (Corscience EMB1 2010, p. 10) 
 
Secondly stainless steel sensors were added to test chair and ECG measured with them. 
After this, distortion increased in whole frequency range of 0,05 – 150 Hz. Lots of high 
frequency transients, presented in figure 26, with high amplitude was noted. This caused 
the amplifier to saturate and finite period of time was required to bring the ECG back. 
In addition, small amplitude base line noise, which reminded electromyography (EMG) 
noise, was noted.  
 
 
Figure 26 (a.) presents effect of a voltage transient on an ECG. (Webster 2010, p. 256, picture modified) 
and (b.) presents EMG interference on the ECG. (Webster 2010, p. 256, picture modified) 
 
Most of the noise was suspected to rise from skin-electrode contact, EMG and move-
ment on skin-electrode contact and so from changing input impedance. To better the 
signal active electrodes made from OPA277 operational amplifier (Teaxas Instruments 
OPA277) were added after sensors. Active electrodes reduce noise by impedance 
matching. Figure 27 presents schema from OPA277 type of active electrode. Active 
electrodes were placed after stainless steel sensors. 
-
+
470 nF
470 nF
GND
+ 15 V
- 15 V
IN
OUT
OP277
 
Figure 27 presents amplifier circuit made to OPA277. 
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After placing active electrodes some distortion was still included into the measured 
ECG signal. According to Lee and Kruse (2008) input bias current on front-end ampli-
fiers can polarize the electrode if there is poor skin electrode contact. Non-polarized 
electrodes are also better than polarized electrodes in terms of their rejection of motion 
artefacts.  Minimizing bias current was seen necessary. Active electrodes were changed 
to AD8627, which provided maximum 1 pA bias current (Analog Devices 2013). Com-
pared to OPA277’s 0,5 nA bias current. Also AD8627 had wide operating voltage (±2,5 
V to ± 13 V), which was close to OPA 277’s  (± 2V to ± 18 V), when health chair pow-
er supply design did not have to be changed. Analogue low pass filter was added to ac-
tive electrode design to filter out high-frequency components. Also after transients’ dig-
ital filters required time to bring back to baseline. Low pass filter was expected to avoid 
this.  
-
6,8 nF
470 pF
470 pF
100 k
100 k
IN +
-
OUT
+ Vdd
- Vdd
AD8627
 
Figure 28 presents schema from designed active electrode AD8627 amplifier circuit with low pass filter. 
Right forearm
Left forearm
Right wrist
Left wrist
AD8627
AD8627
EMB1 ECG module
R input
F input
L input
N input
Vdd +
Vdd -
Vdd -
Vdd +
GND
GND
 
Figure 29 presents designed measurement circuit with AD8627 active electrodes and EMB1 ECG mod-
ule. 
 
Geddes and Baker (1968, p.241-246) conducted square wave, with known voltage and 
current, through different electrode materials and measured the surface area and ampli-
fier input impedance for materials. They noted the same small amplitude noise on base-
line as we, when using stainless steel electrode material. Geddes and Baker (1968, 
p.245) explained that silver-silver chloride, silver, and copper are less noisy materials 
than stainless steel. Silver-silver chloride was the least noisy. There was more baseline 
noise in silver, but copper had more baseline drift. Stainless steel produced the poorest 
result. They conclude that loading caused distortion, because when the electrode polari-
45 
 
 
 
zation impedance becomes dominant part of the input circuit and the voltage across the 
input terminals of the recorder is reduced. Secondly, the amount of phase shift is differ-
ent for various frequency components. With loading, the electrode current density is 
increased and the resistive and reactive components of the electrode polarization imped-
ance become nonlinear, resulting in the magnitude of the electrode polarization imped-
ance becoming a function of the amplitude of the event. Thus small and large amplitude 
signals will encounter different impedances (Geddes &  Baker 1968, p. 240-245) Based 
on this, the measurement electrodes were changed to silver electrodes. It is assumed that 
human skin and especially human sweat includes lot of chloride ions, which in contact 
with silver electrode make more conductive surface.  
6.4 Software of the third pilot 
RR and QT interval calculations were made in EMB1 VI presented in appendix 1. R 
wave was detected after Decoding ECG signal VI. EMB1 module sent 0x0772-
command immediately after detecting R wave. This packet command was recommend-
ed to host R wave triggering. (Corscience EMB1 2010, p. 32)  Third and fourth bytes in 
data packet structure presented in table 1were named command bytes. Command bytes 
were waited after Decoding ECG Signal VI. When program received the commands it 
gave each R wave a millisecond timer value, which was used in pulse transit time calcu-
lation. This time was also put into shift register. This R wave time was used to calculate 
RR time intervals. Each RR time interval was result of subtraction between R wave and 
previous R wave taken from shift register. This command was also used to chop RR 
intervals in QT interval detection. 
 
QT interval detection was made in following way. After Unpack ECG VI, the band stop 
Bessel filter was used to frequency range of 49-51 Hz and also a low-pass inverse Che-
bysev filter was used to limit the frequency range to 150 Hz. After this data array was 
put into shift register. Program read ECG data from shift register. Amount of data read 
to shift register was limited by R wave, so that the data between two consecutive R 
waves was read to shift register. Modules own hardware R wave detection was used to 
chop data into shift registers (Corscience EMB1 2010, p.32).  When data was read, VI 
found T peak after R wave. Threshold value was set to avoid detecting too small peaks.  
After T peak detection next valley was found, this was the end of T wave.  Now pro-
gram took time from previous wave’s R peak to Q valley from shift register and calcu-
lated QT interval. After finding end of T wave, P peak was searched. Threshold value 
was set to find values large enough. After finding P wave next valley was searched 
which was supposed to be Q valley. This Q valley time, from R peak to Q valley, was 
put into shift register and used in next QT interval detection. This next QT interval de-
tection used this Q time of previous RR interval data. After it searched end of T wave 
from its data and calculated the QT interval time again. Figure 30 clarifies chopping of 
RR interval data and QT interval calculations from two consecutive RR intervals. 
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Figure 30 clarify how QT interval was detected from two consecutive RR intervals. 
 
PTT values were calculated from peak of R wave to peak of PPG wave. McCarthy (et 
al. 2011) and Zakaria (et al. 2010) used this method. Pulse transit time calculation was 
conducted in parallel with EMB1 VI presented in appendix 1 and EG00352 VI present-
ed in appendix 4. In addition one while loop was made to update local variables “R 
wave time” and “PPG peak time”. R wave was detected in EMB1 VI with help of spe-
cific command bytes 0x0772. When R wave was detected millisecond timer value was 
updated to local variable called “R wave time”. EG00352 VI detected PPG peak from 
data following 0xF8 marked byte. Wave samples were transmitted 50 samples per sec-
ond, which limited pulse transit time accuracy to 20 ms (Medlab EG00325 2012, p.10). 
Previous chapters and appendix 4 describes more detail functioning of EG00352 VI. 
Peak of PPG wave was detected with Peak Detector VI. Threshold value was set to 100. 
When peak detector triggered a millisecond timer value was updated to local variable 
“PPG peak time”. From this time 20 ms were subtracted because peak detection trig-
gered always too late. This systematic error was noted when PPG signal was drawn with 
Matlab and peak detection times were compared to peak times seen from Matlab. After 
PPG peak detection next peak would be ignore if it would appear inside 300 ms. This 
was done to avoid detecting dictoric notch as a PPG peak. PTT times were calculated in 
another while loop with help of R wave time and PPG peak time local variables. To 
secure that one local variable time was not read two times, PTT calculating loop used 
“PTT val” flag. This loop checked “PTT val” to false after a read and EG00352 loop 
checked “PTT val” to true when PPG peak was detected, so PTT value was only update 
after PPG peak detection. To verify that R wave was detected only once “R found” flag 
was set to true when R wave was detected and set to false when PPG peak was detected.  
PTT was only calculated when “PTT val” was set to true. PPG peak detection was ig-
nored if R wave was not found before it.  PTT calculation loop also calculated ΔPTT, 
which was difference between consecutive pulse transit times. This was done inserting 
previous PTT value to shift register. Another while loop was set to calibrate and calcu-
late blood pressure estimations from pulse transit times. Systolic blood pressure was 
estimated with two different methods:  
 
1. With method presented by Chen (et al. 2000) described previously 
2. With taking two different reference point from systolic blood pressures and 
pulse transit times and estimating blood pressure with help of these points 
47 
 
 
 
 
Method presented by Chen (et al. 2000) used equation 13 to estimate systolic blood 
pressure. In equation systolic blood pressure was estimated with known base blood 
pressure (Pb) and corresponding PTT value (Tb). Chen also used constant γ, which de-
scribed elastic modulus of the vessels. Systolic blood pressure was estimated with 
calculated changes in pulse arrival times (ΔT). 
 
Our idea was to take two reference points with typical systolic blood pressure and 
corresponding PTT value and also higher systolic blood pressure and its corre-
sponding PTT value. Typical values were measured in relaxed state. Second values 
were measured after and during physical activity. It was noted during the tests and 
before the tests that physical activity raises blood pressure for certain amount of 
time. As mentioned when arterial pressure increases the pulse wave travels more quick-
ly and lowers pulse transit time and conversely when blood pressure decreases PTT 
lengthens (Zakaria et al. 2010; Larkin 2005, p. 35).  The idea was to get two reference 
points and estimate systolic blood pressure from pulse transit times with help of 
straight. With help of two known point straight can be drawn between and factors m and 
b can be solved. 
 
          (21) 
          (22) 
 
Factor b can solved from equation 21. 
 
          (23) 
  
Inserting equation 23 in equation 22 solves factor m. 
 
   
     
     
    (24) 
 
Placing equation 24 to equation 23 solves factor b.  
 
      (
     
     
)      (25) 
 
Calibration of systolic blood pressure estimation and the estimation process was made 
in one separate while loop. First PTT values were measured during one minute, while 
this minute blood pressure should be measured with blood pressure cuff. Measured sys-
tolic blood pressure value was added to program. Mean value was calculated from rec-
orded PTT values. The mean value worked as x2 value for straight blood pressure esti-
mation method and base blood pressure (Pb) presented by Chen (et al. 2000). Measured 
blood pressure value was set to y2, which was also corresponding PTT value (Tb) for 
Chen's method.  Elastic modulus (γ) coefficient of the vessels was set to 0.018. 
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After first calibration second calibration was made. During tests grip strength me-
ter was squeezed during one minute to raise blood pressure level.  After second 
calibration loop was started. During this loop PTT values were recorded during 
one minute. From these PTT values mean value was calculated. Systolic blood 
pressure was again measured during one minute’s calibration.  The mean value 
worked as x1 and systolic blood pressure value as y1 for straight blood pressure 
estimation method. Second calibration values were not used in Chen's method. 
After calibration, loop solved m and b values presented in equation 24 and 25 for 
straight blood pressure estimation method.  Then loop also set "Calibrated" flag to 
true, when program started to show PTT values and estimate BP values. Program 
estimated BP values from each PTT values. These values were recorded in 30 sec-
onds intervals from which mean value was calculated. This mean value was rec-
orded in test.   
6.5 Discussion on the third pilot 
As mentioned earlier third pilot design was not finished during this master’s thesis. 
Some development ideas could be mentioned about the subjects the thesis discussed. In 
QT valley detection QT was detected to Q valley, but according to Malmivuo & Plon-
sey (1995) it should have been detected from the beginning of Q wave. It can be 
supposed that this can affect a few to tens of milliseconds too low QT values. 
Threshold values in detection of QT interval were problematic. As mentioned, detection 
of P and T peaks was used in detection of Q valley and T peak. Noisy signal affected 
that some or many of these valleys of peak were detected to wrong location. According 
to tests, amplitude of theses valleys and peaks is individual in most persons. Setting 
threshold values too high would affect that some or none of peaks would be undetected. 
On the other hand setting it too low, would affected that peaks were triggered in wrong 
locations. PTT values were calculated from peak of R wave to peak of PPG wave. This 
was done in matter of simplicity. One idea was to calculate PTT values by indexing 
each sample taken by EMB1 ECG module and EG00352 module. Problematic was that 
EMB1 module send samples to computer in arrays in 50 ms to 100 ms intervals. 
EG00352 PPG module sends samples in bytes in 20 ms intervals.  This clearly lowers 
the accuracy of PPG peak detection. PTT values were confirmed by drawing PPG and 
ECG signals with Matlab. PTT values drawn with Matlab and calculated by LabVIEW 
matched. Unfortunately, in long term recordings there was noted that distance between 
R wave and PPG signal increased during time. The failure was noted in Matlab when 
signals where plotted using sampling frequencies producer promised. EMB1 had sam-
pling frequency of 1 kHz (Corscience EMB1 2010, p. 10 ) and EG00352 50 Hz (Medlab 
EG00352 2012, p.10)  Probably sampling interval of EMB1 or EG00352 is different 
than promised by producer. Even 0,001 ms fail would cost 0,001x5x60x1000 = 300ms 
error after five minutes recording with sampling rate of 1 kHz. If accuracy of calculat-
ing PTT would be main focus of a research, same internal clock would be required for 
both OEM modules. This would eliminate errors, which can appear from two different 
internal clocks. Due to this problem PTT values were calculated using tick counter 
times, not indexes.  
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7 Tests and results 
7.1 Aim of the tests 
We conducted two separate tests series: firstly to verify that measurements can be done 
with second pilot design and secondly to test the functionality of RR and QR interval 
calculation and estimation of systolic blood pressure with pulse arrival time for health 
chair third pilot design. First test series was supposed to verify that following measure-
ments can be done with second pilot design: 
 Blood pressure 
 Weight 
 Bioelectrical impedance 
 Blood oxygen saturation 
 Heart rate 
 Photoplethysmography 
The aim of the second test was to test and verify the functionality and accuracy of ECG 
signal’s RR and QT intervals measure from it. The aim was also to verify the function-
ality of blood pressure estimated from pulse arrival time. 
7.2 Tests and results 
Measurements were made to five test persons from different age categories and with 
basic health. Firstly, measurements were made with health chair second pilot. The re-
sults were analysed. Secondly, test persons ECG was measured with EMB1 ECG mod-
ule and RR and QT intervals were measured with made LabVIEW program. Thirdly, 
test persons ECG and PPG were measured and pulse transit time was measured. Blood 
pressures were estimated using PAT and blood pressure were also measured using cuff 
blood pressure measurement. 
 
Measurements were conducted for five persons from different age categories. All of the 
test persons were healthy and without known cardiovascular diseases. Before tests, per-
sons were questioned about age and gender. Test persons weight, height and maximum 
grip strength were measured. Weight was measured with commercial personal scale for 
which producers give an accuracy of 100 grams. Height was measured with centimetre 
measure. Maximum grip strength was measured with Electronic Hand Dynamometer 
EH101 produced by Gloway Invent. Produces gives it an accuracy of (± 0,5 kg/ 1 lb). 
(Golway Invent 2012) Table 8 presents measured parameters from five test persons. 
 
Table 8 presents firstly measured parameters from test persons 
Test Person A B C D E 
Age: 59 31 29 61 54 
Gender: M M M M F 
Weight (kg): 93,1 101,8 76,4 83,3 66,4 
Height (m): 1,78 7,76 1,73 1,73 1,62 
Max grip (kg): 32,7 54,7 45,7 44,2 21,6 
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After measuring properties presents in table 8, measurements were conducted with 
health chair’s second pilot design. Test procedure started when test person sat on the 
chair. After, blood pressure measuring cuff and PPG finger clip was attached. Test per-
son was asked to place hand on stainless steel sensor on the health chair’s armrests. Af-
ter this, measurement was conducted with health chair’s measurement procedure. Table 
9 presents measured parameter from each test person. 
 
Table 9 presents measured parameters from second pilot design 
Test Person A B C D E 
Weight (kg): 74 113 78 93 70 
HR (1/min.): 81 60 53 71 69 
Impedance (Ω): 178 144 152 158 206 
Ox. Sat (%).: 98 96 98 95 96 
BP sys. (mmHg): 163 125 117 142 110 
BP dia. (mmHg): 100 79 71 87 73 
 
Aim of the test was to verify that measurements could be done with second pilot. 
Weight of test persons was measured before the test to have a reference. Second pilot 
design measured weight of test person A too low. Measured weight was 93,1 kg but the 
result of the test was 74 kg. Difference was 19,1 kg Measurements for test person B, C, 
D and E were conducted on different day. For these measurements results were too 
high. Differences were 11,2 kg, 2,9 kg, 9,7 kg and 3,6 kg in order from test person B to 
E. These results, compared to reference weights, refer that weight was measured but 
accuracy was low.  Low accuracy could have been a result from coupling of all four 
leads of weight measurements sensors to one analogue input of Arduino board. Higher 
accuracy could have been reached with coupling each lead wire to one analogue input of 
Arduino. This way each signal could be filtered and measured separately. Also, filtering 
of weight measurement signal could be redesigned. According to Webster (2010, p. 
153) typical human heart rate is about 70 beats per minute. Measured heart rates of all 
test persons gave typical hear rate values. Mean value was calculated from measured 
impedance values, which were measured from 10 kHz to 100 kHz. Measurement system 
also used stainless steel electrode sensors. Blomqvist (et al 2012) conducted impedance 
measurements with different wet-electrodes from abdominal fat. He got impedance val-
ues varying 20 Ω to 120 Ω. All of the test persons had higher impedance than this.  
Probably affecting factors to measurements are used stainless steel sensor and senor-
skin contact, which is known to be less conductive on dry-electrode interface than wet-
electrode interface. Test person C and E were females. Females have typically higher fat 
percentage than males, when impedance is higher. This can be seen as positive sign 
when considering reliability of measurement. To give a statement about reliability of 
measurement it would require deeper investigation, but considering statements above 
we consider that we were measuring at least partially human impedance. Healthy indi-
viduals blood oxygen saturation values should be over 95 % (Moyle 2002, p. 82). Test 
persons A, B and E had over this value and C and D this value. Patients’ blood oxygen 
saturations were close to this value. According to Larkin (2005, p. 19) normal systolic 
blood pressure is under 130 mmHg and diastolic under 85. Test persons B, C and E ful-
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filled normal blood pressure limits. Person A and D had higher blood pressure but these 
persons were also older, which can affect to blood pressure values.  
 
After second pilot design tests, tests to measure ECG’s RR and QT intervals were con-
ducted. Aim of the test was to compare the results made with automated LabVIEW 
measurements and manually calculated result with Matlab. Ag/Ag-Cl wet electrodes 
(Ambu Blue Sensor L) were attached to test person. Arm electrodes were attached on 
right and left side few centimetres below collateral bones. Leg electrodes were attached 
above of highest point of ilium. This attachment is described in manual of EMB1 
(Corscience EMB1 2010, p. 46). During measurement test persons were sitting on office 
environment. Tests persons’ ECG was measured and recorded during one minute during 
which QT and RR intervals were calculated by LabVIEW program. ECG signal was 
measured with EMB1 ECG module. RR and QT intervals were measured with programs 
introduced. Appendices 8, 11, 13, 16 and 19 introduces results from measured and cal-
culated RR and QT intervals from test persons A, B, C, D and E. In appendices “Meas-
ured RR” and “Measured QT” describes RR interval measured with LabVIEW pro-
gram. In appendices “Calculated RR” and “Calculated QT” describes manually calcu-
lated QT and RR intervals. These intervals were calculated manually from recorded 
ECG signal, which was drawn with Matlab program. Following Matlab sketch was 
made to draw ECG signal: 
 
%% ECG data was read before this from .txt file to dataecg 
%% ECG drawing 
Fs1 = 1000; 
N1=length(dataecg); 
n = 0:1:(N1-1); 
time1 = n./Fs1; 
figure(1); 
plot(time1,dataecg); 
title('Person A ECG'); 
xlabel('time'); 
 
Figure 31 present that RR intervals were calculated from peak of R wave to next R 
peak. QT interval was calculated from the beginning of Q wave to the end of T wave. 
 
 
Figure 31 presents ECG signal drawn with Matlab. RR interval was calculated from peak of R wave to 
the peak of next wave and QT interval was calculated from the beginning of Q valley to the end of T 
wave. 
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Table 10 presents median values from measured and calculated RR and QT intervals, 
their median differences and their standard deviations (σ). Appendix 8, appendix 11, 
appendix 13, appendix 16 and appendix 19 present the test results from measured and 
calculated RR and QT values.   
 
Table 10 presents median values and standard deviations from measured and calculated RR and QT inter-
vals. 
Test person A B C D E 
Measured RR median: 1170 907 1320 1322,5 1094 
Calculated RR median: 1180 938 1333 1350,5 1108 
Median difference: -11 -28 3 -38 -18 
Measured RR σ: 46,33 44,01 51,95 37,89 29,64 
Calculated RR σ: 81,67 125,83 82,00 83,09 84,32 
Measured QT median: 387 364 411 375 387 
Calculated QT median: 426 421 453 481 460 
Median difference: -50 -57 -44 -109 -83 
 Measured QT σ: 347,89 143,99 21,99 230,13 280,00 
Calculated QT σ: 27,77 39,47 22,79 24,73 30,66 
 
Table 10 reveals that median differences of RR interval detection stays under 1 % , de-
spite of person B who has 3 %, compared against “Measured RR median”. “Measured 
RR median” was time measured with LabVIEW. Measured RR standard deviation (σ) 
tells that RR intervals stay under 55 ms close to their average. Median differences of 
QT intervals compared against values measured with LabVIEW are 12,9 %; 15,6 %; 
10,7 %; 30 % and 21,4 % in order from A to E.  Automatically measured QT standard 
deviations are large on test persons A, B, D and E. Test person C has smallest standard 
deviation and QT intervals have been narrowly spread. RR intervals have larger stand-
ard deviation from manual calculation than with automated LabVIEW calculation. This 
speaks that automated measurements are more precise than manual calculations. In case 
of QT intervals situation is opposite. Manually calculated results (“Calculated QT σ”) 
have smaller standard deviation than with results measured with LabVIEW (“Measured 
QT σ”).  
 
Appendices 9, 12, 14, 17 and 20 present drawn Bland-Altman plots where mean values 
and differences between two methods are presented. Bland-Altman plots are supposed 
to describe precision of measured values. As can be seen from theses appendices preci-
sion of RR interval detection is spread to small area. Few larger differences between 
measurements can be detected on each test person. The phenomena imply that algorithm 
cannot detect every R peak, because it is detected with manual examination. Precision 
of all point RR interval points is satisfying. I suspect that small fluctuation between RR 
intervals is natural. Precision of QT interval detection is widely spread on test persons 
A, B, D, and E. QT intervals of test person C have been spread on small area, in appen-
dix 14. In appendix 12, test person B has few erroneous measurements but majority of 
QT intervals are on narrow area. On tests persons A, D and E (in appendices 9, 17 and 
20) QT intervals have been spread. These persons have clearly detectable groups of QT 
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intervals on smaller area and these groups are more widely spread. I assume that these 
refer to systematic error. This systematic error can rise from peak or valley detection 
method used. Probably on these cases T peak, P peak, Q valley or the end of T wave 
cannot clearly be detected by algorithm. Also, PQRST- complex is individual and can 
vary depending on person. Noise on the signal could have been caused error to QT in-
tervals. Figure 32 presents two QRST-complexes from each test person.  
 
 
Figure 32 present two PQRST complexes from each test person. 
 
After testing test persons RR and QT detection, blood pressure was estimated with pulse 
transit time from each test person. Test persons were seated in office environment dur-
ing the test. ECG signal of test persons was measured with EMB1 ECG module. Same 
electrodes and electrode attachments were used as described in previous chapter. PPG 
signal was measured with EG00352 pulse oxymeter board (Medlab EG00352 2012).  
Pulse oximeter finger clip was attached to left little finger. Blood pressures were meas-
ured from right arm of the patient with Omron M6 Comfort Blood Pressure meter 
(model HEM-7000-E). Producer promises accuracy of ± 3 mmHg to it (Omron 2013). 
Patient also squeezed grip strength meter with his right hand. 
 
Tests were firstly calibrated to estimate blood pressure from pulse transit times. First 
calibration was done after starting PPG and ECG signal measurements. It was done 
without physical activity. In the calibration stage, test person was relaxed and PTTs 
were measured during one minute. Mean value for pulse arrival times was calculated, 
which gave reference value to higher PTT. During calibration systolic blood pressure 
was measured with blood pressure cuff attached to right arm of the patient. This value 
gave reference to lower blood pressure value. After first calibration, test person was 
asked to squeeze grip strength meter for one minute with half from maximum grip 
strength. After one minute of squeeze it was continued and second calibration was start-
ed. Again one minute of PTT values were recorded and mean value was calculated from 
it. This gave reference value to lower PTT.  This time measurement was done during 
physical activity.  During squeeze and PTT calculation systolic blood pressure was 
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measured.  This gave reference to higher blood pressure value. After the calibrations, 
test persons PTTs were recorded. These PTT values were compared against lower and 
higher PTT values with known systolic blood pressure values. With this comparison 
blood pressure values were estimated from measured PTT values.  Blood pressures were 
estimated and recorded during four minutes. Before one-minute blood pressure estima-
tion was done without physical activity.  After one-minute to the end of measurement, 
which lasted four minutes, was recorded squeezing with half force from maximum grip 
strength. During this measurement systolic blood pressure values were estimated using 
PTT’s. Following list clarifies measurement procedure: 
 
 1st calibration 
o No physical activity 
o Systolic blood pressure measured 
o PTTs measured and mean value calculate from them 
 2nd calibration 
o Physical activity 
o Systolic blood pressure measured 
o PTTs measured and mean value calculate from them 
 0th minute measurement 
o No physical activity 
o PTTs measured and systolic BP estimated 
 1st minute measurement 
o Systolic blood pressure measured in time 1:00 
o Physical activity added after measurement 
o PTTs measured and systolic BP estimated 
 2nd minute measurement 
o Physical activity 
o Systolic blood pressure measured in time 2:30 
o PTTs measured and systolic BP estimated 
 3rd minute measurement 
o Physical activity 
o Systolic blood pressure measured in time 3:30 
o PTTs measured and systolic BP estimated 
 
Hey (et al. 2009) estimated length of pulse arrival time to be 0,11- 0,475 seconds 
measured from R peak to P base point of PPG wave. Our measurements introduce 
that pulse transit times varies around 300 -550 ms measured from R peak to peak 
of PPG.  Calculated medians were 509 ms from person A and B, 422 ms from per-
son C,  469 ms from person D and E. Comparing this to numbers introduced by Hey 
measured PTTs are large, which is obvious because of later PPG measurement 
point . Measured PTTs can be considered reliable. The results from measured PTTs 
during 4 minutes measurements are presented in appendices 10, 12, 15, 18 and 21. 
 
Figure 33 has been drawn from table 11. It presents estimated blood pressures measured 
from test person A. Column “Estimated BP dPTT” presents estimated systolic blood 
pressures with method introduced by Chen (et al. 2000). Column “Estimated BP 
straight” introduces systolic blood pressure values estimated with help of two reference 
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points. Column “Sys BP” presents systolic blood pressure values measured with cuff 
blood pressure measurement device Omron M6 Comfort. “Difference dPTT” is the dif-
ference between  “Estimated BP dPTT” and “Sys BP”. “Difference straight” is the dif-
ference between “Estimated BP straight” and  “Sys BP”.  
 
Table 11 present estimated and measured blood pressures from person A 
min 
Estimated 
BP dPTT 
Estimated 
BP straight 
Sys BP 
Difference 
dPTT 
Difference 
straight 
0,5 141 139 
   1 177 168 154 -23 -14 
1,5 141 138 
   2 141 139 
   2,5 204 187 168 -36 -19 
3 141 140 
   3,5 141 139 181 40 42 
4 141 141 
    
 
Figure 33 presents systolic blood pressure estimations and measured systolic blood pressures from test 
person A. 
 
In figure 33 measured blood pressure raises almost linearly. From figure 33 we can see 
that “Estimated BP dPTT” and “Estimated BP straight” behaves almost same way. In-
crease in systolic BP can be seen in times of one and two and half minutes in both esti-
mation methods. Both estimation methods give low blood pressure values at the begin-
ning when person was note doing physical activity, which yields to lower values. “Es-
timated BP dPTT” estimates BP a bit higher than “Estimated BP straight”. Measured 
systolic blood pressure has been measured with in certain point of time. Estimated 
blood pressure has been estimated continuously. Figure 33 reveals that both blood pres-
sure estimation methods follow “Sys BP” in two first points. Following of the third 
point cannot be noted in this chart, but could happen later because the “Sys BP” meas-
urement was made from right hand of the patient. Same hand gripped the strength me-
ter, which can raise blood pressure in right hand faster than in whole body. PTT estima-
tion method estimated whole body blood pressure.   
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Table 12 present estimated and measured blood pressures from person B 
min 
Estimated 
BP dPTT 
Estimated 
BP straight Sys. BP 
Difference 
dPTT 
Difference 
straight 
0,5 123 122       
1 124 121 117 -7 -4 
1,5 117 122       
2 117 122 
 
    
2,5 117 122  123 -117 -122 
3 117 122 
 
    
3,5 117 123 131 -117 -123 
4 126 121       
 
 
Figure 34 presents systolic blood pressure estimations and measured systolic blood pressures from test 
person B. 
 
Table 12 presents measured and estimated systolic blood pressure values from test per-
son B. Figure 34 has been drawn from table 12. Figure 34 reveals that measured “Sys 
BP” increases almost linearly during measurement.  “Estimated BP straight ” and “Es-
timated BP dPTT” behaves almost linearly. “Estimated BP dPTT” seems under estimate 
systolic blood pressure a bit more than “Estimated BP straight”. Both methods seem to 
be quite precise in time of one minute and one and half minute. In time of three minute 
both estimation methods get less precise. 
 
Table 13 present estimated and measured blood pressures from person C 
min. 
Estimated 
BP dPTT 
Estimated 
BP straight 
Sys. BP 
Difference 
dPTT 
Difference 
straight 
0,5 113 113       
1 113 113 115 2 2 
1,5 112 113       
2 167 120       
2,5 113 113 125 12 12 
3 113 113       
3,5 113 112 139 26 27 
4 114 113       
 
0
20
40
60
80
100
120
140
0,5 1 1,5 2 2,5 3 3,5 4
Estimate BP dPTT
Estimated BP
straight
Sys. Bp
57 
 
 
 
 
Figure 35 presents systolic blood pressure estimations and measured systolic blood pressures from test 
person C. 
 
Tests done for test person C reveals with help of table 13 and 35 that differences “Esti-
mated BP dPTT” and “Estimated BP straight” measurement points are the same, but 
Chen’s method has a large increase in time of two minutes. “Estimated BP straight” has 
a small increase in estimated systolic blood pressure but does not yield to significant 
increase. As in all previous tests, here as well “Sys BP” increases almost linearly. Here 
neither estimation methods does follow the systolic blood pressure, but could follow it 
if the measurement would be longer. I assume that whole body’s blood pressure does 
not increase that fast as local blood pressure in right arm. Table 13 reveals that both 
estimation method have exactly same difference with systolic BP values in times of one 
minute and two and half minute.  
 
Table 14 present estimated and measured blood pressures from person D 
min 
Estimated 
BP dPTT 
Estimated 
BP straight 
Sys. BP 
Difference 
dPTT 
Difference 
straight 
0,5 141 130       
1 133 131 118 -15 -13 
1,5 117 147       
2 137 127       
2,5 117 148 136 19 -12 
3 143 121       
3,5 166 107 147 -19 40 
4 142 122       
 
 
Figure 36 presents systolic blood pressure estimations and measured systolic blood pressures from test 
person D. 
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From table 14 and from figure 36 we can see that “Sys BP” increases almost linearly. 
“Estimated BP dPTT” and “Estimated BP straight” behaves inversely. Interestingly in 
one minutes time, which has been measured when test person has been relaxed, is al-
most the same. In two minutes and half time when physical activity has been included 
“Estimated BP dPTT” under estimated and “Estimated BP straight” over estimated the 
value. At the point of tree and half minute the estimations change to opposite. “Estimat-
ed BP dPTT” have smaller median difference which speaks about it could be more ac-
curate on test person D. 
Table 15 present estimated and measured blood pressures from person E 
min. 
Estimated 
BP dPTT 
Estimated 
BP straight 
Sys. BP 
Difference 
dPTT 
Difference 
straight 
0,5 106 167       
1 132 108 111 -21 3 
1,5 106 161       
2 105 159       
2,5 106 162 127 21 -35 
3 106 162       
3,5 106 162 152 46 -10 
4 153 92       
 
 
Figure 37 presents systolic blood pressure estimations and measured blood pressures measured from 
person E. 
 
Figure 37 revels that “Estimated BP dPTT” estimates systolic blood pressure lower 
compared to again almost linearly increasing systolic blood pressure. “Estimated BP 
straight” shows estimated blood pressure almost correctly in point of one-minute time. 
After, it estimates blood pressure too high and drops down in after tree and half minutes 
point. “Estimated BP dPTT” show a bit more accurate median difference in table 15 
than “Estimated BP straight”. 
 
To summarize the tests, estimated systolic blood pressure was compared against systolic 
blood pressure values measured with intermittent cuff method. With cuff measurement 
a single determination of blood pressure was obtained. Cuff estimated systolic blood 
pressure had linear growth, which was aimed and achieved. Two systolic blood pressure 
estimation methods were compared and systolic blood pressure was estimated with 
them. In two from five tests inverse behaviour between estimation methods was noted. 
In three from five tests both estimation method had same behaviour. This can be algo-
rithm depended. Both estimation methods had different estimation algorithms. Differ-
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ence in behaviours can be explained that other method (“Estimated BP straight”) used 
two calibration points instead of one. The median differences between estimation meth-
ods varied widely. Larger scale test would be needed to separate the estimation methods 
precision. More tests would also be needed to decide which of the methods is more 
convenient to clinical use. Main difficulty in this method is that the elasticity of the ves-
sels walls is not constant. The elasticity of the arterial wall differs from individual to 
individual and is affected by neuro-humoral factors. Some authors recommended re-
calibration between PTT and measured systolic BP at 5 minutes intervals to the method. 
Considering these results calibration is essential and re-calibration would be recom-
mended. Considering these results the method is neither compatible for determine abso-
lute blood pressure or detecting small changes of blood pressure but could be compati-
ble for monitoring blood pressure in long periods.   
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7.3 Conclusion 
In the thesis ECG was measured with dry-electrodes with satisfying quality, the blood 
pressure was estimated with pulse transit time and RR and QT intervals were measured. 
ECG was measured with Ag-electrodes with using active electrodes and ECG module 
presented. PTT estimation method was used for continuous non-invasive systolic blood 
pressure estimation with using re-calibration in short-term intervals. According to re-
sults systolic blood pressure can be estimated using calibration and measuring PTT val-
ues. In measurement arrangement more continuous BP values would have been ar-
chived with invasive measurement. I suspect that errors in cuff placement can yield to 
some errors in BP values.  With invasive method this could be avoided, but the method 
would complicated the test process with necessary medical permissions and presence of 
medical personnel. Increase of BP was done with squeezing grip strength meter. In-
crease could have been done with medication or other kind of physical activity. Medica-
tion would have needed authorizations. All kind of physical activity needs muscle 
movement, which can add error to BP measurement. Grip strength meter was seen 
proper way. In measurement arrangement test person was sitting on the chair. Other 
option could be that test person would be lying on the bed. I suspect that lying position 
is not recommendable position to cuff BP measurement, if so this method would possi-
ble require invasive BP measurement method. More accurate measurements would have 
been received from PPG peak detection if sampling frequency of module had been larg-
er. In used module, sampling frequency was 50 Hz. Measurement system was done with 
two separate OEM modules and with one LabVIEW program. The information pro-
cessing speed of the program stayed unknown. One solution to measurement arrange-
ment would be designing a system, which measures both ECG and PPG using one in-
ternal clock. One internal clock would possible that the program could assume that the 
intervals between received samples are the same. In this way PTT could be calculated 
from sample intervals. Sampling frequency of the system should be set to high. Then 
time intervals would stay constant between samples and error between two different 
clocks would not sum during time. This way using counter clocks inside the program 
would be avoided. It would simplify the measurement and avoid the possible errors ris-
ing from them. 
 
Considering the results, BP estimation method is compatible for systolic blood pressure 
estimation when re-calibration is used. QT interval measurement had good precision on 
one of the test persons. With RR interval measurements satisfying accuracy was reached 
with all of the test persons. To assure their compatibility to real human diagnostics QT 
interval detection should be designed differently. It should achieve satisfying precision 
on all of the test persons. Considering all of the method introduced more larger scale 
test would be needed before these designed methods could be used in clinical use. If the 
elasticity of the vessel could be known the systolic blood pressure estimation using PTT 
would enable new method for blood pressure estimation. It would have large impact 
commercially and in clinical use.  
 
Considering health chair’s RR and QT interval economic value, it is large as they form 
necessary part from its ECG diagnostic it enables. The economic value of health chair 
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can be large. It decreases the time used to measurement by fastening the measurement 
procedure. With appropriate operating system it could send the measurement to external 
server where health care personnel could analyse the data. This would ease analysing 
health data and would allow automated alarm setting when unhealthy signs are detected. 
Also, this would enable long-term patient monitoring and disease diagnostic from home 
or from health care facility. Also, health chair could cut down health device cost by in-
tegrating all necessary measurements to one concept. This would enable manufacturing 
on large scale and it would cut down device costs. 
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8 Summary 
This master’s thesis was part of larger development process, which aimed to realize a 
health chair for monitoring patient state of health. It was a research of Aalto Universi-
ty’s Health Factory. It was participated also by the Institute of Healthcare Engineering, 
Management and Architecture (HEMA). Aim of this master’s thesis was to participate 
in to technical development of the health chair by realizing wanted measurements to 
health chair pilot designs from selected modules. This includes doing all the necessary 
coupling and programming to implement wanted measurements. In addition, aim was to 
design automated calculations of RR and QT intervals from ECG module and test their 
compatibility in use. Aim was also to design, execute and test estimating of patient 
blood pressure with pulse transit time method. Two different estimating methods was 
implemented and tested. The thesis introduced a design of dry-electrode contact electro-
cardiography measurement from chosen ECG module. It also collects information relat-
ed to realize pilot designs measurements. 
 
The thesis introduces health chair’s first pilot design, which worked as test platform to 
test the chosen measurement modules and verify their compatibility to use. Realization 
of measurements was made with EMB1 electrocardiography module, ChipOx photople-
thysmography module, openEBI electrical bioimpedance module and weight sensors. 
Necessary LabVIEW programs were made to monitor the measurements. Secondly the 
master's thesis introduces second health chair pilot design. The design was more devel-
oped and it included blood pressure, weight, photoplethysmography, electrical bioim-
pedance, blood oxygen saturation and heart rate measurements. All these measurement 
were executed on this health chair. The thesis also introduces made LabVIEW programs 
to monitor measurement modules and understand its operating system made. The third 
pilot design was not realized to the end during this master’s thesis, although work done 
and introduced in this master’s thesis play essential role in its measurements. The third 
pilot design was designed to include electrocardiography, weight, bioelectrical imped-
ance, blood oxygen saturation, hear rate and photoplethysmography measurements and 
systolic blood pressure estimation from pulse transit time. The thesis introduces realized 
dry-electrode ECG measurement and two realized systolic blood pressure estimation 
methods. RR and QT interval calculations and BP estimation methods were made with 
LabVIEW. The designs of these programs are presented. 
 
This master’s thesis present tests made to five persons from different age categories. 
Firstly, functioning of second pilot design measurements were tested. Aim of the test 
was to verify that measurements could be done with second pilot design. Results are 
present in the thesis and refer that all the tests were done. Secondly, compatibility of RR 
and QT intervals calculations were tested. Aim of the test was to compare the results 
made with automated LabVIEW measurements and manually calculated result with 
Matlab. The results are presented. RR interval calculations had small standard deviation 
and median error than QT interval calculations. RR interval calculations were consid-
ered precise. Lastly, systolic blood pressure was estimated with measured pulse transit 
times from these five test persons. Two different estimation methods were used. Con-
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sidering the results the method is neither compatible for determine absolute blood pres-
sure or detecting small changes of blood pressure but could be compatible for monitor-
ing blood pressure in long periods.   
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Appendix 1. Presents EMB1 VI where its parts EMB1 Request ID VI, CRC 16 CCIITT VI, Protocol Analog Req VI, Decoding ECG signal VI and Unpack ECG block diagrams. 
1 page. 
EMB1 Request ID VI Protocol Analog Req VICRC16 CCIITT VI Decoding ECG Signal VI
Unpack ECG VI
Check next serial 
port for device if 
available.
Open and configure 
serial port. Set Baud 
rate 115200.
Is there error?
Is there errors?
Yes
No
Send No EMB1.
Close serial port and 
send no EMB1.
Yes
Send identification 
inquiry command 
(0x0500) to CRC16 
CCIITT VI.
No
Read message.
Write it to serial 
port.
Read serial port. 
Check if identification 
is enough long?
No
Yes
Check that 
identification is 
Corscience 
EMB1?
No
Send serial port 
Protocol Analog 
Request VI.
Rotate string, add it 
to the end of the 
string, insert start 
flag and end flag 
into the string. Send 
string.
Make the checksum.
Shift every byte with 0xFFFF;
x = ((crc>>8)^data) & 0xff;
x^=x>>4;
crc=(crc << 8)^(x<<12)^(x<<5)^x
 crc &= 0xffff;;
Take VISA 
reference.
Check if No 
EMB1 send?
Yes
No
EMB1  VI
Send protocol 
version inquiry.
Write it to serial 
port and read 
property node.
Check if request 
is correct?
Yes
No
Send config analoag 
request command.
Read property  node 
and check if the answer 
is  one ECG channel and 
sampling rate 1kH?.
Send VISA reference 
out and boolean 
true.
Send boolean 
value false.
Yes
No
Is EMB1 
configured 
succesfully?
Stop EMB1 
execution.
No
Yes
Is Start ECG 
transmission 
pushed?
Is Stop ECG 
trasnmission 
pushed?
Send Start ECG 
transmission to 
CRC16 CCIITT VI.
Stop ECG 
trasnmission.
No
Yes
Yes
No
Is received bytes 
larger than 0?
No
Send bytes to 
Decoding ECG signal 
VI.
Yes
Can you find 
Start flag?
Is start flag the 
first element?
Start flag is not first 
element
we delete 
everything till start 
flag 
Put array to Shift 
register output.
No
Yes
No
Can you find end 
flag?
No
Yes
Take the piece of 
the array from start 
flag to end flag.
Is command 
0x24 at index 2?
Delete array.
Is command 
0x07 at index 3?
No
No
Covert all:
0xFE 0xDC to 0xFC
0xFE 0xDD to 0xFD
0xFE 0xDE to 0xFE
Yes
Yes
Show HR from 
element 6. Take 
ECG payload and 
send it to Unpack 
ECG VI.
Is command 
0x72 at index 2?
Delete array.
Is element 7 at 
index 3? 
R wave is detected. 
Calulate time 
interval between 
serial R.waves.
No
Yes
No
Yes
Draw ECG signal.
Take value to Shift 
register.
Is mask bit 1 or 
0?
It is 2 byte value.
1
0
Is sign bit 1 or 0?
Shift mask bit away, 
add 0 to MSB and 
conjugate next 
element from array 
to the next element. 
0
1
Shift mask bit away, 
add 1 to MSB and 
conjugate next 
element from array 
to the next element.
Is sign bit 1 or 0?
Shift mask bit away, 
add 0 to MSB and 
add 0's to missing 
first byte to make it 
2 byte value.
Shift mask bit away, 
add 1 to MSB and 
add 1's to missing 
first byte to make it 
2 byte value. 
1
0
Send Upacked 2 
byte value to EMB1 
VI.
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Appendix 2. Presents block diagrams of ChipOx user interface, Find ChipOx and ChipOx decodingVIs. 1 page. 
Program starts
Open serial ports 
and wait 300 ms.
Clear VISA and wait 
1 s.
Check is there 
error status?
Read bytes at port.
Check if 0xA8 
0x7F is found?
Yes
No
Send ChipOX port to 
main program
Yes
No
Find ChipOx VI ChipOX  VI
Configure Serial 
port
Visa Flush
Read bytes at port
ChipOx decoding VI
VISA clear.
Send no ChipOx.
Is start flag first 
element?
Is end flag last 
element?
Check is 7F at 
index 1?
Delete end flag, 
start flag and 
checksum.
Replace all serial 
values 0xa9 0x88 
with  0xa8 and 0xa9 
0x89 with 0xa9.
Draw pulse and 
oxygen saturation 
values and 
photoplethysmogra
phy signal.
Is there start 
flag in the array
Put in to shift 
register.
Delete everything 
before start flag.
Put array into shift 
register.
Delete array.
Yes
NoNo
Yes
No
Yes
No
Yes
Is 0x51 real-time 
data channelat index 
0?
No
Yes
Delete array.
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Appendix 3. A broad-minded block diagram arrangements of connection, modules and other devices in pilot two. 1 page. 
openEBI 
Bioimpedance 
board
NIBScan Blood 
Pressure board
Arduino Uno
INA122P amplifier 
coupling
NIBScan testkit
Regulator 
coupling
EG00352 Pulse 
oximeter board 
and testtest kit
U
SB
 b
u
s
Medical grade power 
supply
15 V
V
-
V
+I+I-
10
Blood Pressure 
measurment hose
PoX measurment
cable
Weight measurment
cables from
each chaor leg
M
ai
n
s 
p
o
w
er
User Monitor
20 V
R
S-
2
3
2
-t
o
 
U
SB
 
co
n
ve
rt
er
RS-232-to-
USB 
converter
USB 2.0 HUB USB bus
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Appendix 4. Block diagram of EG00352 VI and Find POX VI. 1 page. 
Find POX VI
Start program
Find serial port.
Open serial port.
Is there errors?
Read bytes at port.
Is there 0xF9 in 
the array?
Can you find 
0xFA after it?
Can you find 
0xFC after it?
VISA close.
Send no POX.
Send serial port to 
main program.
Yes
No
No
No
No
Yes
Yes
Yes
EG00352
Configure serial 
port.
Read bytes at port.
Is the byte 
smaller than 
0xF8
Pu it to shift 
register.
Is the value 
0xF8?
Is the value 
0xF9?
Is the value 
0xFA?
Is the value 
0xFD?
Is the value 
0xFC?
Quality and 
perfusion index 
follows.
Pulse value follows.
SpO2 value follows.
Draw the PPG 
values from shift 
register.
What info byte 
follows?
0x00: OK
0x01: Sensor 
Disconnected.
0x02: No finger in probe.
0x03. Low perfusion.
0x45: Selftest Error
Yes
Yes
Yes
Yes
Yes
Yes
Value is something 
else. Don’t do 
nothing.
No
No
No
No
No
No
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Appendix 5. Block diagram of Find NIBP VI and NIBP VI. 1 page.  
Find NIBP VI
Check next serial 
port for device if 
available.
Open and configure 
serial port. Set Baud 
rate 4800.
Is there error?
Is there errors?
Yes
No
Send No NIBP.
Close serial port and 
send No NIBP.
Yes
Send Read status 
frame from slave.
Is status 
correct?
Send boolean NIBP 
found and NIBP 
serial port. 
NIBP VI
Send received serial 
port.
Send Select adult 
measuring mode
Is Start Measuring 
button pushed?
No
Yes
Send start 
measuring 
command.
Is there bytes at 
port?
Show cuff pressure 
in mmHG after first 
character.
Is commandC0 
at index 4?
Send problems 
deteced in cuff.
Send No problems 
detected.
Is end charter 
found?
Send measuring.
Send not 
measuring.
No
Yes
Yes
No
Yes
No
Read status from 
slave.
Does read bytes 
match to regular 
pattern?
Show systolic 
pressure at index 0, 
diastolic pressure at 
index 3 and pulse 
rate at index 11.
Close serial port.
Yes
No
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Appendix 6. Block diagram of Z VI and Find Z VI. 1 page. 
Find Z VI
Check next serial 
port for device if 
available.
Open and configure 
serial port. Set Baud 
rate 19200.
Is there errors?
Yes
No
Send No Z.
Send ’s’ to module
Read bytes at port. 
Z VI
Flush serial port and 
start impedance 
measurment with ’s’ 
command.
Is there enough 
bytes at port?
No
Yes
Can you find 
regular expression 
’0D0A’ from 
substing?
No
Send serial port of 
impedance moudle.
Yes
Read bytes at port.
Reverse input string 
and read first 
character.
Is first chracter 
$?
Change string values 
’\.’ to ’,’.
No
Yes
Convert string to 
array and use 
delimiter  ’;’ on 
spreadsheet .
Read frequency 
values from 1 to 49.
Calulate absolute 
value from complex 
impedance 
numbers.
Draw frequency and 
impedance graph 
and calulate mean 
value. Show them 
to user.
abbc-(b+)=ac VI
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Appendix 7. Block diagram clarifies function of Weight VI, A/B xtrac VO and Find Weight VI. 1 page. 
Find Weight VI
Check next serial 
port for device if 
available.
Open serial port. .
Is there errors?
Yes
No
Send No Arduino.
Read bytes at port. 
Weight VI
Flush serial port and 
send it to A/B xtrac 
VI.
Is there enough 
bytes at port?
No
Yes
Can you find 
regular expression 
’-Arduino-’ from 
substing?
No
Send serial port 
Arduino.
Yes
A/B xtrac VI
Read serial port and 
find substring from 
string. 
Can you find W 
from substing?
Simulate weight.
Send weight to 
Weight VI.
No
Yes
Show  raw 
bodyweight to user. 
Add constant body 
weight to raw body 
weight.
Multiply it with 
body wieight 
coefficient.
Calulate mean value 
from it.
Is patient 
standing?
Read 25 values from 
raw body weight 
and calculate mean 
value from them to 
body weight.
Read 25 values from 
raw body weight 
and calculate mean 
value from them to 
negated body 
weight constant.
Yes
No
Show body weight 
to user.
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Appendix 8. Presents measured and calculated RR, QT intervals and their differences from test person A. 1 page. 
 
Person A  
       
 
 
 
Measured 
RR: 
Calculated 
R: 
Calculated 
RR:: Diff: 
Measured 
QT: 
Calculated 
QT: Diff: min. 
Measured BP 
dPTT: 
Measured BP 
straight: 
Sys 
BP 
 
391 
     
  
 
 
1174 1597 1206 -32 352 473 -121 0,5 141 139  
1190 2814 1217 -27 392 462 -70 1 177 168 154 
1215 4039 1225 -10 49 453 -404 1,5 141 138  
1233 5291 1252 -19 26 424 -398 2 141 139  
1213 6537 1246 -33 399 449 -50 2,5 204 187 168 
1246 7813 1276 -30 48 451 -403 3 141 140  
1257 9077 1264 -7 405 449 -44 3,5 141 139 181 
1234 10030 953 281 408 451 -43 4 141 141  
1242 11283 1253 -11 36 445 -409       
1237 12530 1247 -10 384 451 -67 
 
    
1247 13747 1217 30 391 422 -31      
1181 14894 1147 34 392 401 -9       
1146 16051 1157 -11 401 442 -41       
1154 17220 1169 -15 399 472 -73       
1182 18337 1117 65 27 416 -389       
1115 19451 1114 1 388 418 -30       
1091 20559 1108 -17 395 457 -62       
1116 21678 1119 -3 44 419 -375       
1130 22792 1114 16 1108 407 701       
1094 23948 1156 -62 1 438 -437       
1124 25062 1114 10 31 438 -407       
1080 26176 1114 -34 387 476 -89       
1125 27322 1146 -21 1115 448 667       
1118 28465 1143 -25 2 511 -509       
1124 29563 1098 26 43 447 -404       
1085 30676 1113 -28 410 425 -15       
1113 31823 1147 -34 44 469 -425       
1138 32959 1136 2 1132 461 671       
1088 34093 1134 -46 398 428 -30       
1143 34960 867 276 35 445 -410       
1157 36106 1146 11 22 367 -345       
1137 37256 1150 -13 394 412 -18       
1156 38460 1204 -48 382 410 -28       
1170 39640 1180 -10 11 422 -411       
1166 40787 1147 19 389 393 -4       
1151 42000 1213 -62 387 395 -8       
1213 43235 1235 -22 1244 426 818       
1206 44424 1189 17 33 400 -367       
1178 45614 1190 -12 421 423 -2       
1197 46863 1249 -52 49 408 -359       
1215 48065 1202 13 11 389 -378       
1189 49249 1184 5 426 438 -12       
1173 50481 1232 -59 375 386 -11       
1228 51677 1196 32 1224 468 756       
1174 52856 1179 -5 390 402 -12       
1158 54077 1221 -63 386 428 -42       
1232 55296 1219 13 25 421 -396       
1171 56452 1156 15 55 401 -346       
1148 57647 1195 -47 378 406 -28       
1182 58853 1206 -24 375 404 -29       
1207 59714 861 346 1212 T wave lost         
1159 60897 1183 -24 831 421 410       
1156 62114 1217 -61             
 
Median diff:    -11   Median diff: -50       
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Appendix 9. Presents RR and QT interval Bland-Altman plots measured from test person A. 1 page. 
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Appendix 10. Presents measured pulse transit times from test person A. 1 page. 
Person A 
 
Pulse transit times: 
    1 509 
 
58 511 
 
115 519 
 
172 502 
2 509 
 
59 499 
 
116 492 
 
173 500 
3 525 
 
60 518 
 
117 481 
 
174 510 
4 502 
 
61 503 
 
118 495 
 
175 508 
5 513 
 
62 493 
 
119 535 
 
176 515 
6 501 
 
63 478 
 
120 504 
 
177 530 
7 503 
 
64 496 
 
121 1581 
 
178 528 
8 482 
 
65 498 
 
122 2648 
 
179 486 
9 502 
 
66 501 
 
123 3716 
 
180 516 
10 510 
 
67 487 
 
124 513 
 
181 504 
11 478 
 
68 528 
 
125 534 
 
182 505 
12 511 
 
69 518 
 
126 533 
 
183 487 
13 513 
 
70 479 
 
127 529 
 
184 505 
14 519 
 
71 529 
 
128 532 
 
185 505 
15 488 
 
72 463 
 
129 518 
 
186 511 
16 509 
 
73 522 
 
130 520 
 
187 536 
17 503 
 
74 505 
 
131 517 
 
188 522 
18 482 
 
75 514 
 
132 518 
 
189 541 
19 506 
 
76 519 
 
133 520 
 
190 530 
20 499 
 
77 517 
 
134 494 
 
191 522 
21 505 
 
78 510 
 
135 495 
 
192 519 
22 505 
 
79 493 
 
136 493 
 
193 522 
23 473 
 
80 475 
 
137 529 
 
194 499 
24 513 
 
81 489 
 
138 508 
 
195 517 
25 502 
 
82 503 
 
139 500 
 
196 507 
26 506 
 
83 485 
 
140 501 
 
197 514 
27 516 
 
84 514 
 
141 537 
 
198 511 
28 513 
 
85 502 
 
142 514 
 
199 529 
29 503 
 
86 504 
 
143 520 
 
200 530 
30 482 
 
87 523 
 
144 529 
 
201 523 
31 507 
 
88 512 
 
145 521 
 
202 514 
32 499 
 
89 497 
 
146 497 
 
203 507 
33 497 
 
90 511 
 
147 512 
 
204 499 
34 522 
 
91 526 
 
148 498 
 
205 524 
35 500 
 
92 506 
 
149 499 
 
206 514 
36 507 
 
93 511 
 
150 524 
 
207 510 
37 483 
 
94 509 
 
151 525 
 
208 519 
38 533 
 
95 511 
 
152 492 
 
209 522 
39 475 
 
96 506 
 
153 521 
 
210 519 
40 538 
 
97 504 
 
154 525 
 
211 537 
41 510 
 
98 507 
 
155 494 
 
212 503 
42 1668 
 
99 516 
 
156 512 
 
213 513 
43 2845 
 
100 516 
 
157 511 
   44 497 
 
101 505 
 
158 516 
   45 484 
 
102 507 
 
159 504 
   46 491 
 
103 515 
 
160 526 
   47 492 
 
104 502 
 
161 502 
   48 484 
 
105 503 
 
162 501 
   49 489 
 
106 500 
 
163 512 
   50 514 
 
107 527 
 
164 495 
   51 514 
 
108 523 
 
165 485 
   52 484 
 
109 517 
 
166 524 
   53 489 
 
110 517 
 
167 504 
   54 494 
 
111 513 
 
168 504 
   55 507 
 
112 1620 
 
169 499 
   56 494 
 
113 2718 
 
170 507 
   57 523 
 
114 498 
 
171 459 
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Appendix 11. Presents measured and calculated RR, QT intervals and their differences from test person 
B. 2 pages. 
Person B : 
          Measured 
RR: 
Calculated 
R: 
Calculated 
RR:: Diff: 
Measured 
QT: 
Calculated 
QT: Diff: 
  
Estimated 
BP dPTT: 
Estimated 
BP straight: Sys. BP 
 
687 
      
min 
  
  
1015 1646 959 56 355 431 -76  0,5 123 122   
952 2657 1011 -59 382 454 -72   1 124 121 117 
977 3672 1015 -38 337 514 -177   1,5 117 122   
1000 4696 1024 -24 1010 415 595   2 117 122 123 
963 5729 1033 -70 331 452 -121   2,5 117 122   
3892 6744 1015 2877 57 556 -499   3 117 122 131 
  7765 1021           3,5 117 123   
  8760 995           4 126 121   
  9772 1012                   
971 10771 999 -28 362 437 -75   
    972 11741 970 2 363 410 -47   
    918 12713 972 -54 354 400 -46   
    937 13682 969 -32 377 432 -55   
    919 14632 950 -31 338 480 -142   
    919 15583 951 -32 367 420 -53   
    957 16532 949 8 383 411 -28   
    918 16542 10 908 347 420 -73   
    957 17483 941 16 945 432 513   
    931 18434 951 -20 324 421 -97   
    962 19158 724 238 127 393 -266   
    969 20108 950 19 369 410 -41   
    973 21087 979 -6 361 188 173   
    944 22029 942 2 386 435 -49   
    967 23002 973 -6 361 404 -43   
    974 24001 999 -25 375 442 -67   
    919 24936 935 -16 349 414 -65   
    955 25918 982 -27 381 423 -42   
    946 26906 988 -42 393 424 -31   
    931 27864 958 -27 376 414 -38   
    889 28789 925 -36 360 419 -59   
    895 29718 929 -34 353 408 -55   
    872 30614 896 -24 367 430 -63   
    880 31501 887 -7 366 406 -40   
    861 32409 908 -47 352 430 -78   
    841 33278 869 -28 375 429 -54   
    859 34163 885 -26 364 413 -49   
    853 35054 891 -38 385 406 -21   
    832 35883 829 3 363 429 -66   
    861 36728 845 16 343 419 -76   
    834 37582 854 -20 348 397 -49   
    932 38512 930 2 951 394 557   
    925 39481 969 -44 327 424 -97   
    923 40449 968 -45 341 408 -67   
    918 41410 961 -43 358 413 -55   
    890 42093 683 207 34 484 -450   
    893 43026 933 -40 358 420 -62   
    
847 43907 881 -34 350 
T wave 
lost 0   
    856 44775 868 -12 398 415 -17   
    851 45636 861 -10 351 447 -96   
    849 46513 877 -28 400 445 -45   
    860 47400 887 -27 347 405 -58   
    860 48321 921 -61 378 445 -67   
    864 49220 899 -35 335 418 -83   
    870 50125 905 -35 389 425 -36   
    875 51063 938 -63 405 400 5   
    907 52023 960 -53 369 426 -57   
    892 52960 937 -45 374 448 -74   
    901 53887 927 -26 357 425 -68   
    906 54802 915 -9 344 429 -85   
    883 55757 955 -72 424 418 6   
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872 56648 891 -19 376 404 -28   
    885 57546 898 -13 369 447 -78   
    869 58470 924 -55 332 433 -101   
    884 59384 914 -30 365 428 -63   
    900 60314 930 -30 383 412 -29   
    905 61254 940 -35 385 407 -22   
    922 62216 962 -40 370 427 -57   
    907 63133 917 -10 382 439 -57   
    904 64099 966 -62 363 420 -57   
    
 
Median diff: -27,5 Median diff: -57 
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Appendix 12. Presents RR and QT interval Bland-Altman plots measured from test person B. 1 page. 
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Appendix 13. Present pulse transit times measured from test person B. 1 page. 
Person B 
 
Pulse transit times: 
    1 509 58 511 115 519 172 502 
2 509 59 499 116 492 173 500 
3 525 60 518 117 481 174 510 
4 502 61 503 118 495 175 508 
5 513 62 493 119 535 176 515 
6 501 63 478 120 504 177 530 
7 503 64 496 121 1581 178 528 
8 482 65 498 122 2648 179 486 
9 502 66 501 123 3716 180 516 
10 510 67 487 124 513 181 504 
11 478 68 528 125 534 182 505 
12 511 69 518 126 533 183 487 
13 513 70 479 127 529 184 505 
14 519 71 529 128 532 185 505 
15 488 72 463 129 518 186 511 
16 509 73 522 130 520 187 536 
17 503 74 505 131 517 188 522 
18 482 75 514 132 518 189 541 
19 506 76 519 133 520 190 530 
20 499 77 517 134 494 191 522 
21 505 78 510 135 495 192 519 
22 505 79 493 136 493 193 522 
23 473 80 475 137 529 194 499 
24 513 81 489 138 508 195 517 
25 502 82 503 139 500 196 507 
26 506 83 485 140 501 197 514 
27 516 84 514 141 537 198 511 
28 513 85 502 142 514 199 529 
29 503 86 504 143 520 200 530 
30 482 87 523 144 529 201 523 
31 507 88 512 145 521 202 514 
32 499 89 497 146 497 203 507 
33 497 90 511 147 512 204 499 
34 522 91 526 148 498 205 524 
35 500 92 506 149 499 206 514 
36 507 93 511 150 524 207 510 
37 483 94 509 151 525 208 519 
38 533 95 511 152 492 209 522 
39 475 96 506 153 521 210 519 
40 538 97 504 154 525 211 537 
41 510 98 507 155 494 212 503 
42 1668 99 516 156 512 213 513 
43 2845 100 516 157 511 
  44 497 101 505 158 516 
  45 484 102 507 159 504 
  46 491 103 515 160 526 
  47 492 104 502 161 502 
  48 484 105 503 162 501 
  49 489 106 500 163 512 
  50 514 107 527 164 495 
  51 514 108 523 165 485 
  52 484 109 517 166 524 
  53 489 110 517 167 504 
  54 494 111 513 168 504 
  55 507 112 1620 169 499 
  56 494 113 2718 170 507 
  57 523 114 498 171 459 
   
  
Appendix 14 (1/1) 
 
 
 
Appendix 14. Presents measured and calculated RR, QT intervals and their differences from test person C. 1 page. 
Person C : 
          Measured 
RR: 
Calculated 
R: 
Calculated 
RR: Diff: 
Measured 
QT: 
Calculated 
QT: Diff: min. 
Estimated BP 
dPTT: 
Estimated BP 
straight: Sys. BP 
 
457 
         1314 1865 1408 -94 393 477 -84 0,5 113 113  
1376 3198 1333 43 400 467 -67 1 113 113 115 
1306 4646 1448 -142 454 453 1 1,5 112 113   
1453 6084 1438 15 445 462 -17 2 167 120 
 1409 7449 1365 44 390 460 -70 2,5 113 113 125 
1335 8876 1427 -92 394 516 -122 3 113 113   
1409 9979 1103 306 440 510 -70 3,5 113 112 139 
1398 11353 1374 24 410 482 -72 4 114 113   
1364 12676 1323 41 386 453 -67 
    1291 14053 1377 -86 434 462 -28 
    1369 15430 1377 -8 457 475 -18 
    1359 16735 1305 54 413 480 -67 
    1287 18120 1385 -98 454 516 -62 
    1373 19438 1318 55 434 473 -39 
    1307 20824 1386 -79 421 465 -44 
    1373 22121 1297 76 411 437 -26 
    1297 23407 1286 11 436 474 -38 
    1287 24745 1338 -51 429 426 3 
    1318 26098 1353 -35 379 440 -61 
    1366 27512 1414 -48 398 442 -44 
    1406 28837 1325 81 420 463 -43 
    1319 30175 1338 -19 430 446 -16 
    1350 31461 1286 64 406 444 -38 
    1286 32827 1366 -80 433 432 1 
    1353 33819 992 361 394 454 -60 
    1266 35143 1324 -58 430 477 -47 
    1320 36415 1272 48 387 443 -56 
    1232 37814 1399 -167 410 435 -25 
    1394 39147 1333 61 406 458 -52 
    1315 40483 1336 -21 412 448 -36 
    1310 41775 1292 18 395 440 -45 
    1295 43029 1254 41 397 449 -52 
    1256 44344 1315 -59 462 432 30 
    1325 R lost     410 441 -31 
    1245 R lost     387 444 -57 
    1330 48143     396 469 -73 
    1202 49429 1286 -84 397 442 -45 
    1288 50711 1282 6 440 416 24 
    1304 52056 1345 -41 412 424 -12 
    1329 53372 1316 13 398 462 -64 
    1321 54694 1322 -1 432 440 -8 
      Median diff: 2,5  Median diff: -44 
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Appendix 15. Presents RR and QT interval Bland-Altman plots measured from test person C. 1 page 
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Appendix 16. Present pulse transit times measured from person C. 1 page. 
  
Person C: Pulse transit times: 
       1 386 48 435 95 427 142 426 189 404 236 425 
2 396 49 431 96 445 143 430 190 397 237 448 
3 426 50 441 97 449 144 470 191 400 238 415 
4 406 51 440 98 455 145 467 192 402 239 431 
5 388 52 414 99 451 146 425 193 409 240 409 
6 405 53 450 100 444 147 460 194 411 241 427 
7 417 54 437 101 462 148 443 195 411 242 435 
8 412 55 442 102 452 149 427 196 406 243 420 
9 431 56 456 103 439 150 437 197 403   
 10 433 57 447 104 435 151 420 198 419 
  11 426 58 439 105 400 152 442 199 405 
  12 415 59 417 106 436 153 417 200 422 
  13 462 60 416 107 409 154 437 201 413 
  14 463 61 411 108 407 155 402 202 414 
  15 446 62 418 109 425 156 431 203 411 
  16 433 63 417 110 435 157 432 204 399 
  17 409 64 411 111 450 158 414 205 399 
  18 414 65 416 112 427 159 435 206 389 
  19 425 66 409 113 454 160 425 207 394 
  20 433 67 401 114 464 161 425 208 400 
  21 423 68 416 115 458 162 439 209 400 
  22 426 69 396 116 448 163 454 210 421 
  23 406 70 398 117 439 164 431 211 448 
  24 416 71 406 118 453 165 429 212 430 
  25 415 72 397 119 461 166 418 213 421 
  26 411 73 411 120 465 167 420 214 419 
  27 424 74 405 121 470 168 408 215 398 
  28 416 75 437 122 449 169 395 216 396 
  29 419 76 416 123 463 170 373 217 411 
  30 408 77 429 124 465 171 402 218 416 
  31 409 78 456 125 440 172 388 219 417 
  32 389 79 434 126 446 173 412 220 391 
  33 382 80 428 127 457 174 400 221 423 
  34 418 81 443 128 441 175 406 222 431 
  35 414 82 1570 129 440 176 405 223 401 
  36 421 83 2588 130 435 177 392 224 386 
  37 399 84 3705 131 434 178 404 225 401 
  38 414 85 467 132 436 179 362 226 418 
  39 413 86 448 133 452 180 392 227 400 
  40 421 87 407 134 440 181 416 228 414 
  41 424 88 419 135 455 182 408 229 398 
  42 393 89 425 136 451 183 415 230 426 
  43 395 90 447 137 472 184 401 231 409 
  44 411 91 444 138 450 185 417 232 420 
  45 424 92 423 139 460 186 397 233 405 
  46 403 93 428 140 466 187 388 234 415 
  47 443 94 425 141 460 188 407 235 429 
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Appendix 17. Presents measured and calculated RR, QT intervals and their differences from test person D. 1 page. 
Person D : 
          Measured 
RR: 
Calculated 
R: 
Calculated 
RR: Diff: 
Measured 
QT: 
Calculated 
QT: Diff: min. 
Estimated BP 
dPTT: 
Estimated BP 
straight: Sys. BP 
 
975 
         1397 2362 1387 10 546 500 46 0,5 141 130  
1352 3790 1428 -76 387 495 -108 1 133 131 118 
1320 5176 1386 -66 46 484 -438 1,5 117 147   
1340 6611 1435 -95 42 478 -436 2 137 127   
1357 8063 1452 -95 40 489 -449 2,5 117 148 136 
1426 9468 1405 21 386 482 -96 3 143 121   
1359 10920 1452 -93 225 492 -267 3,5 166 107 147 
1431 12337 1417 14 544 446 98 4 142 122   
1380 13705 1368 12 540 448 92 
    1354 15033 1328 26 403 464 -61 
    1345 16370 1337 8 589 478 111 
    1334 17396 1026 308 590 407 183 
    1317 18734 1338 -21 42 477 -435 
    1346 20016 1282 64 41 481 -440 
    1300 21337 1321 -21 546 471 75 
    1342 22588 1251 91 53 470 -417 
    1255 23893 1305 -50 536 465 71 
    1288 25204 1311 -23 35 479 -444 
    1335 26537 1333 2 608 505 103 
    1293 27890 1353 -60 50 455 -405 
    1358 29212 1322 36 53 462 -409 
    1310 30552 1340 -30 535 450 85 
    1352 31863 1311 41 407 471 -64 
    1328 33171 1308 20 383 456 -73 
    1277 34496 1325 -48 536 434 102 
    1342 35789 1293 49 367 462 -95 
    1277 37213 1424 -147 33 500 -467 
    1345 38574 1361 -16 397 486 -89 
    1298 39922 1348 -50 54 461 -407 
    1347 41282 1360 -13 45 492 -447 
    1322 42410 1128 194 631 530 101 
    1325 43869 1459 -134 55 492 -437 
    1286 45209 1340 -54 632 492 140 
    1286 46562 1353 -67 42 534 -492 
    1305 47921 1359 -54 387 489 -102 
    1274 49250 1329 -55 486 449 37 
    1296 50751 1501 -205 48 471 -423 
    1323 52222 1471 -148 572 496 76 
    1277 53599 1377 -100 40 465 -425 
    1344 54859 1260 84 39 487 -448 
    1271 56233 1374 -103 44 535 -491 
    1319 57726 1493 -174 197 504 -307 
    1302 59046 1320 -18 44 495 -451 
    1292 60383 1337 -45 514 480 34 
    1309 61753 1370 -61 40 483 -443 
    1313 63166 1413 -100 408 517 -109 
    
 
Median diff: 
 
-37,5 Median diff: 
 
-109 
    
Appendix 18 (1/1) 
 
 
Appendix 18. Presents RR and QT interval Bland-Altman plots measured from test person D. 1 page 
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Appendix 19. Present pulse transit times measured from test person D. 1 page. 
Person D 
 
Pulse transit times: 
    1 402 58 482 115 513 172 487 
2 454 59 467 116 481 173 464 
3 455 60 451 117 490 174 467 
4 463 61 485 118 487 175 468 
5 433 62 470 119 462 176 457 
6 430 63 460 120 1745 177 455 
7 445 64 470 121 3002 178 478 
8 416 65 474 122 458 179 489 
9 427 66 476 123 457 180 481 
10 430 67 483 124 474 181 482 
11 460 68 458 125 468 182 455 
12 447 69 475 126 479 183 464 
13 470 70 470 127 490 184 469 
14 464 71 458 128 452 
  15 466 72 474 129 483 
  16 477 73 453 130 458 
  17 465 74 463 131 462 
  18 498 75 487 132 482 
  19 461 76 484 133 464 
  20 478 77 478 134 477 
  21 1695 78 142 135 458 
  22 2892 79 580 136 465 
  23 463 80 460 137 477 
  24 458 81 475 138 480 
  25 492 82 461 139 463 
  26 466 83 461 140 479 
  27 475 84 1738 141 465 
  28 475 85 2825 142 463 
  29 475 86 491 143 475 
  30 473 87 480 144 465 
  31 476 88 475 145 464 
  32 483 89 472 146 1681 
  33 470 90 468 147 4065 
  34 456 91 462 148 447 
  35 498 92 460 149 498 
  36 475 93 466 150 471 
  37 475 94 474 151 466 
  38 464 95 461 152 496 
  39 453 96 461 153 472 
  40 464 97 467 154 457 
  41 463 98 470 155 477 
  42 492 99 463 156 467 
  43 462 100 455 157 468 
  44 488 101 473 158 447 
  45 485 102 465 159 462 
  46 448 103 468 160 469 
  47 465 104 447 161 468 
  48 457 105 461 162 465 
  49 471 106 463 163 1682 
  50 487 107 465 164 2920 
  51 471 108 472 165 478 
  52 478 109 473 166 499 
  53 470 110 454 167 482 
  54 467 111 480 168 490 
  55 465 112 443 169 479 
  56 474 113 476 170 475 
  57 482 114 462 171 469 
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Appendix 20. Presents measured and calculated RR, QT intervals and their differences from test person E. 1 page. 
Person E : 
          Measured 
RR: 
Calculated 
R: 
Calculated 
RR: Diff: 
Measured 
QT: 
Calculated 
QT: Diff: min. 
Estimated 
BP dPTT: 
Estimated 
BP straight: Sys. BP 
 
268 
         965 1325 1057 -92 968 424 544 0,5 106 167  
1022 2419 1094 -72 352 489 -137 1 132 108 111 
1055 3492 1073 -18 389 481 -92 1,5 106 161   
1061 4553 1061 0 1077 438 639 2 105 159   
1027 5674 1121 -94 347 483 -136 2,5 106 162 127 
1059 6859 1185 -126 393 486 -93 3 106 162   
1101 7997 1138 -37 401 509 -108 3,5 106 162 152 
1075 9155 1158 -83 419 514 -95 4 153 92   
1090 10301 1146 -56 416 479 -63 
    1129 11625 1324 -195 63 520 -457 
    1124 12757 1132 -8 449 470 -21 
    1125 13958 1201 -76 65 460 -395 
    1121 15091 1133 -12 378 440 -62 
    1136 16208 1117 19 398 440 -42 
    1114 17318 1110 4 391 440 -49 
    1100 18492 1174 -74 374 450 -76 
    1123 19281 789 334   T lost   
    1089 20370 1089 0 14 460 -446 
    1078 21478 1108 -30 381 430 -49 
    1110 22681 1203 -93 381 460 -79 
    1133 23786 1105 28 42 480 -438 
    1093 24876 1090 3 401 480 -79 
    1084 25993 1117 -33 396 470 -74 
    1104 27129 1136 -32 978 510 468 
    1096 28212 1083 13 40 440 -400 
    1075 29295 1083 -8 420 460 -40 
    1084 30415 1120 -36 382 430 -48 
    1120 31521 1106 14 61 500 -439 
    1076 32609 1088 -12 354 500 -146 
    1075 33705 1096 -21 1075 470 605 
    1096 34792 1087 9 387 430 -43 
    1110 35856 1064 46 387 470 -83 
    1072 36942 1086 -14 399 480 -81 
    1085 38233 1291 -206 387 500 -113 
    1103 39422 1189 -86 393 490 -97 
    1074 40568 1146 -72 428 450 -22 
    1077 41666 1098 -21 425 430 -5 
    1118 42770 1104 14 60 460 -400 
    1111 43865 1095 16   T lost   
    1079 44677 812 267 37 410 -373 
    1096 45864 1187 -91 42 500 -458 
    1119 47071 1207 -88 61 460 -399 
    1072 48183 1112 -40 1195 500 695 
    1094 49342 1159 -65 373 460 -87 
    1100 50435 1093 7 495 520 -25 
    1086 51649 1214 -128 35 490 -455 
    1128 52907 1258 -130 38 450 -412 
    1099 54019 1112 -13 67 450 -383 
    1085 55109 1090 -5 381 450 -69 
    1104 56204 1095 9 387 450 -63 
    1099 57279 1075 24 38 360 -322 
    1084 58350 1071 13 64 460 -396 
    1080 59440 1090 -10 412 480 -68 
    1094 30415 1108 -18 387 460 -83 
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Appendix 21. Presents RR and QT interval Bland-Altman plots measured from test person E. 1 page. 
 
 
 
 
  
y = -1,4073x + 1527,5 
R² = 0,6156 
-300
-200
-100
0
100
200
300
400
0 200 400 600 800 1000 1200 1400
D
if
fe
re
n
ce
 (
m
s)
 
Mean (ms) 
Person E RR mean vs. diff. 
y = 1,9049x - 892,67 
R² = 0,9538 
-600
-400
-200
0
200
400
600
800
0 200 400 600 800 1000
D
if
fe
re
n
ce
 (
m
s)
 
Mean (ms) 
Person E QT mean vs. diff. 
 Appendix 22 (1/1) 
 
 
 
Appendix 22. Present pulse transit times measured from test person E. 1 page. 
Person E 
 
Pulse transit times: 
    1 402 58 482 115 513 172 487 
2 454 59 467 116 481 173 464 
3 455 60 451 117 490 174 467 
4 463 61 485 118 487 175 468 
5 433 62 470 119 462 176 457 
6 430 63 460 120 1745 177 455 
7 445 64 470 121 3002 178 478 
8 416 65 474 122 458 179 489 
9 427 66 476 123 457 180 481 
10 430 67 483 124 474 181 482 
11 460 68 458 125 468 182 455 
12 447 69 475 126 479 183 464 
13 470 70 470 127 490 184 469 
14 464 71 458 128 452 
  15 466 72 474 129 483 
  16 477 73 453 130 458 
  17 465 74 463 131 462 
  18 498 75 487 132 482 
  19 461 76 484 133 464 
  20 478 77 478 134 477 
  21 1695 78 142 135 458 
  22 2892 79 580 136 465 
  23 463 80 460 137 477 
  24 458 81 475 138 480 
  25 492 82 461 139 463 
  26 466 83 461 140 479 
  27 475 84 1738 141 465 
  28 475 85 2825 142 463 
  29 475 86 491 143 475 
  30 473 87 480 144 465 
  31 476 88 475 145 464 
  32 483 89 472 146 1681 
  33 470 90 468 147 4065 
  34 456 91 462 148 447 
  35 498 92 460 149 498 
  36 475 93 466 150 471 
  37 475 94 474 151 466 
  38 464 95 461 152 496 
  39 453 96 461 153 472 
  40 464 97 467 154 457 
  41 463 98 470 155 477 
  42 492 99 463 156 467 
  43 462 100 455 157 468 
  44 488 101 473 158 447 
  45 485 102 465 159 462 
  46 448 103 468 160 469 
  47 465 104 447 161 468 
  48 457 105 461 162 465 
  49 471 106 463 163 1682 
  50 487 107 465 164 2920 
  51 471 108 472 165 478 
  52 478 109 473 166 499 
  53 470 110 454 167 482 
  54 467 111 480 168 490 
  55 465 112 443 169 479 
  56 474 113 476 170 475 
  57 482 114 462 171 469 
   
